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9aBstract
According to the literature, the risk for emotional symptoms, anxiety and social 
dysfunction is increased among youth with inflammatory bowel disease (IBD). 
Previous studies in this area are, however, sparse and in those that do exist, 
methodological problems occur. Frequency of sleep disturbances, daytime tiredness, 
and psychosocial symptoms related to sleeping difficulties in paediatric IBD are so 
far unstudied. The current study aimed to evaluate the frequency of psychosocial 
symptoms and sleep problems among Finnish adolescents with paediatric IBD 
compared to population-based controls. Both parents and adolescents themselves 
were used as a source of information. 
The data was collected in spring 2007 as a postal questionnaire-based survey. 
Parents and adolescents received standardised questionnaires that measured 
adolescents’ psychosocial symptoms, competence, sleep, and daytime tiredness 
(Child Behavior Checklist, CBCL, for parent; Youth Self-Report, YSR, and Sleep 
Self-Report, SSR, for adolescents). The final study includes 160 (56%) adolescents 
with IBD and 236 (27%) controls with their parents. The groups of patients and 
controls were similar according to demographic and descriptive characteristics 
(gender, age, place of residence and socio-economic status), and represented the 
whole country well. 
In the first study, parent and self-reported psychosocial symptoms and 
competence were evaluated among adolescents with IBD in comparison to the 
controls, and in the patients, according to severity of IBD symptoms. The main 
findings here were that the patients reported equally as much psychosocial problems 
in self-reports as the controls did, even though their parents reported significantly 
more emotional symptoms, somatic complaints, social problems, thought problems, 
and lower competence in their children compared to the parents of controls. The 
frequency of psychosocial problems correlated positively with the severity of IBD 
symptoms according to both respondents. This study suggests that self-rated 
questionnaires may not be efficient enough to measure psychosocial well-being of 
adolescents with IBD and, thus, complementary assessments should be applied. 
Furthermore, psychosocial evaluation especially among patients with severe IBD 
symptoms should be routinely applied in clinical visits. Parental evaluation is of 
great value and should be included in the psychosocial assessment of adolescents 
with IBD.
The second study assessed parent-adolescent agreement regarding emotional, 
behavioural and somatic symptoms in adolescents with IBD. In 5% of the cases, 
parents and adolescents agreed on the presence of a psychosocial problem, but 
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in 21% of the cases they disagreed. According to both respondents, no problems 
existed in 74% of the cases. Altogether, the parent-adolescent agreement rate was 
poor to low, being lowest on anxious/depressed mood and thought problems, 
and highest on social problems. The parents reported significantly more often 
somatic symptoms close to clinical range (subclinical) in their adolescents than the 
adolescents themselves did. These results indicate that in patients with paediatric 
IBD, parents and adolescents often disagree on patient’s psychosocial problems and 
somatic complaints. Clinically significant psychosocial and somatic problems would 
stay unrecognised in this patient group without asking about these symptoms from 
both the parents and the adolescents themselves.
The third study evaluated frequency of parent and self-reported sleep problems 
and daytime tiredness among adolescents with IBD in relation to the controls and, 
in the patient group, in relation to the severity of the disease. The results revealed 
that, according to the parental perception, adolescents with IBD are burdened with 
more frequent sleep disturbances and overtiredness than the controls. However, 
self-reported sleep problems and daytime tiredness were equally common in both 
groups. Parent and self-reported sleep problems and overtiredness associated 
positively with the self-reported severity of IBD symptoms. Thus, especially those 
adolescents with IBD who suffer from severe symptoms of the disease should be 
further assessed for sleep disturbances and daytime tiredness.
Finally, the fourth study examined parent and self-reported psychosocial 
symptoms and somatic complaints in sleep-troubled (n=32) versus non-sleep 
troubled adolescents with IBD (n=125). According to both respondents, the sleep-
troubled patients had more frequent psychosocial problems (especially anxiety/
depressed mood and aggressive behaviour) and somatic complaints (various 
aches and nausea) than their counterparts without sleep trouble. Additionally, 
SSR-measured sleep quality correlated significantly with parent and self-reported 
attention problems. These results indicate that in those adolescents with IBD who 
self-perceive sleeping difficulties, further assessment of psychosocial symptoms 
and proper evaluation of somatic symptoms is needed, as are the interventions to 
improve sleep quality among them.
11
introduction
Colitis ulcerosa and Crohn’s disease are collectively known as inflammatory bowel 
disease (IBD). It has been estimated that in Scotland and Sweden the prevalence of 
paediatric IBD is around 22/100 000 (Armitage et al., 2001;Hildebrand et al., 1994). 
For an unidentified reason, the number of paediatric IBD cases is growing both in 
Finland and worldwide (Benchimol et al., 2011;Lehtinen et al., 2011;Turunen et al., 
2006). In Finland, the incidence of IBD nearly doubled in 1987-2003 (Turunen et 
al., 2006), and it continues to rise at an average rate of 6-8% per year (Lehtinen et 
al., 2011). IBD often affects adolescents and young adults but its appearance at any 
age is possible (Loftus and Sandborn, 2002;Loftus, 2004). The etiology of IBD is 
unknown (Geier et al., 2007). Genotype seems to be the main predisposing factor 
for the disease. However, it accounts only for 10% in colitis ulcerosa and 25% in 
Crohn’s disease. There is no cure for IBD. The symptoms can, however, be treated 
and revealed.
Serious chronic somatic conditions, such as IBD, may markedly influence 
physical, psychological and social developmental processes and cause extra stress 
during adolescence, which in turn may increase vulnerability to psychosocial 
problems (Lavigne and Faier-Routman, 1992;Mackner and Crandall, 2007;Michaud 
et al., 2004;Suris et al., 2004;Taylor et al., 2008). The symptoms of IBD may be harsh 
(e.g. abdominal pain, diarrhoea, rectal bleeding, fatigue, growth failure, delayed 
sexual maturation, sleep disruptions), and the course of the disease is unpredictable. 
Previous studies show that IBD negatively affects mental health and psychosocial 
functioning, and may predispose the patients to psychiatric disorders (Burke et 
al., 1989;Burke et al., 1994b;Canning, 1994;Engstöm and Lindquist, 1991;Mackner 
et al., 2004). Furthermore, the disease may have a stressful impact on all family 
members and have a negative influence on family functioning (Engström, 1999). 
It has also been shown that families of chronically ill children use mental health 
services at a high rate (Gortmaker et al., 1990). 
With the increasing incidence of paediatric IBD, it has become more important 
to understand the impact of the disease on the everyday life, social capability, 
and mental health of the adolescents with IBD. Paying attention to psychosocial 
issues in clinical practice is needed to achieve the best success with the treatment 
of paediatric patients and their families. For example, psychosocial factors may 
influence compliance to medication (Hommel et al., 2008). Recognising a further 
need for psychosocial support in this population is also needed. Psychosocial issues 
among adolescents with IBD have not previously been assessed in the Finnish 
population. 
12
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There is increasing evidence of the importance of sleep on the health and 
overall well-being of growing children and adolescents. Sleep disturbances among 
adolescents in the normal population are common (Owens, 2008). Paediatric 
patients with various somatic or psychiatric conditions suffer from sleep problems 
even more frequently than their peers in the community (Bandla and Splaingard, 
2004;Ivanenko and Gururaj, 2009;Owens, 2008). Many sleep disturbances 
in paediatric patients go unrecognised by health care providers (Glassroth, 
2004;Mindell et al., 1994). Sleep troubles associate with emotional and behavioural 
problems, and may have an excessive impact on everyday life and performance 
at school and social surroundings (Dahl, 1996;Fallone et al., 2002;Lavigne et al., 
1999;Owens et al., 2005;Sadeh et al., 2002). Adult studies indicate that sleep 
problems are more common among adult patients with IBD compared to healthy 
controls (Keefer et al., 2006;Ranjbaran et al., 2007a;Zimmerman, 2003). So 
far, studies evaluating the frequency of disturbed sleep, daytime tiredness, and 
psychosocial symptoms related to sleeping difficulties among adolescents with 
paediatric IBD are lacking. Thus, paying attention to the quality of sleep and the 
consequences of a poor night’s sleep among paediatric patients with IBD is of 
great value.
The present dissertation work investigated psychosocial symptoms and sleep 
problems among Finnish paediatric IBD patients compared to community-based 
controls. In the patient group, the frequency of psychosocial symptoms and sleep 
problems according to the severity of IBD symptoms were also investigated, as were 
the psychosocial and somatic symptoms that associate with trouble sleeping in this 
population. The current study collected data from both parents and adolescents, 
and thus the evaluation of parent-adolescent agreement regarding psychosocial 
symptoms and somatic complaints was included.
13
finnish summary 
Tutkimuksen tavoitteena oli selvittää psykososiaalisten oireiden, uniongelmien 
ja päiväväsymyksen yleisyyttä kroonista tulehduksellista suolistosairautta 
(Inflammatory bowel disease, IBD) sairastavilla suomalaisnuorilla. Tutkimusaineisto 
kerättiin postitse standardoiduilla kyselylomakkeilla (Child Behavior Checklist, 
CBCL; Youth Self-Report, YSR; Sleep Self-Report, SSR), jotka mittaavat lasten ja 
nuorten psykososiaalisten oireiden ja kompetenssin sekä uniongelmien määrää. 
Kyselylomakkeisiin vastasivat sekä vanhemmat (CBCL) että nuoret itse (YSR, SSR). 
Potilasryhmässä vastauksia palautui 160 (56%) nuorelta ja kontrolliryhmässä 236 
(27%) nuorelta.
Potilaat raportoivat itsellään saman verran psykososiaalisia oireita, uniongelmia 
ja päiväväsymystä kuin kontrollinuoret. Vanhempien mukaan potilailla oli 
kuitenkin merkittävästi enemmän tunne-elämän oireita, somaattisia vaivoja, 
ongelmia sosiaalisessa elämässä ja ajatustoiminnoissa sekä enemmän unihäiriöitä 
ja päiväväsymystä kuin kontrolleilla. Samoin potilaiden kokonaiskompetenssi oli 
heidän mukaansa kontrolleihin verrattuna alhaisempi. 
Tämän tutkimuksen perusteella psykososiaalisten oireiden, unihäiriöiden 
ja päiväväsymyksen yhteys suolistotaudin oireiden vaikeusasteeseen oli selvä. 
Potilasnuoret ja heidän vanhempansa raportoivat enemmän psykososiaalisia 
oireita, unihäiriöitä ja päiväväsymystä suolistotaudin suhteen hankalasti oireilevilla 
potilailla kuin niillä, joiden tauti oli vähäoireinen. 
Unihäiriöisillä potilailla oli enemmän psykososiaalisia ongelmia (erityisesti 
ahdistus- ja masennusoireita, aggressiivisia käytösoireita ja somaattisia vaivoja) kuin 
niillä, jotka nukkuivat omasta mielestään ongelmitta. Somaattisista oireista erityisesti 
erilaiset kivut ja pahoinvointi olivat yhteydessä uniongelmaan. Huonolla yöunen 
laadulla oli sekä vanhempien että nuorten mukaan yhteys keskittymisongelmiin. 
Vanhemmat raportoivat potilasnuorilla enemmän vakavia somaattisia oireita kuin 
nuoret itse. Nuoret sen sijaan tunnistivat itsellään enemmän käyttäytymiseen 
ja sosiaaliseen elämään liittyviä vakavia ongelmia kuin heidän vanhempansa. 
Kaiken kaikkiaan potilasnuorten ja heidän vanhempiensa välinen yhteisymmärrys 
psykososiaalisista oireista oli heikolla tasolla.
Kliinisessä työssä tulisi kiinnittää huomiota psyykkiseen ja sosiaaliseen 
hyvinvointiin ja yöunen laatuun erityisesti niillä kroonista tulehduksellista 
suolistosairautta sairastavilla nuorilla, jotka itse kokevat suolistotautinsa oireet 
hankaliksi. Kroonista tulehduksellista suolistosairautta sairastavan nuoren kokema 
uniongelma antaa aiheen selvittää hänen psykososiaalisia oireitaan tarkemmin. 
14
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1 Paediatric inflammatory Bowel disease
Inflammatory bowel disease (IBD) is a collective term for chronic relapsing 
autoimmune-type inflammatory conditions of the gastrointestinal (GI) tract 
known as Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative 
colitis differ mainly according to the anatomical location of inflammation. Crohn’s 
disease potentially affects the whole GI tract, while ulcerative colitis is located only 
in the large intestine. Furthermore, in ulcerative colitis the intestinal inflammation 
is limited to the innermost layer of the intestinal wall, while in Crohn’s disease it 
may spread through the entire thickness of the intestinal wall. In about 10% of cases 
it is impossible to distinguish between Crohn’s disease and ulcerative colitis, and 
therefore the disease is called unclassified colitis (or indeterminate colitis, IC). At 
long-term follow-ups as the disease progresses, some of these cases can be classified 
as Crohn’s disease or ulcerative colitis (Hanauer, 2006). 
1.1. etioLogy
The main causes for IBD are yet to be fully understood. However, genetic (Binder, 
1998;Satsangi et al., 1998), environmental (Bernstein et al., 1999;Lashner, 1995), 
and immune factors (Sartor, 1995;Shanahan and Anton, 1988) seem to play a role 
in the pathogenesis. The most commonly accepted hypothesis for the cause of IBD 
suggests that in affected patients, genetic predisposition to altered innate mucosal 
immune response against luminal antigen (pathogenic or normal enteric organism) 
causes abnormal mucosal inflammation in the GI tract (Baumgart and Carding, 
2007;Nieuwenhuis and Escher, 2008). Over 30% of those who are diagnosed with 
IBD before they are 20 years of age have other family members with IBD, indicating 
a marked genetic influence on the onset of the disease (Farmer, 1989). However, 
genetics alone offer insufficient explanation for the disease. Several environmental 
factors, such as non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, viral 
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and bacterial infections, have been identified as being partly responsible for the 
development of IBD (Mayer, 2010). 
1.2. epidemioLogy
For unknown reasons, the incidence of paediatric IBD is rising in many Western 
countries (Armitage et al., 2001;Barton et al., 1989;Cosgrove et al., 1996;Lindberg 
et al., 2000) including Finland (Turunen et al., 2006). In Finland, the mean annual 
incidence of paediatric IBD nearly doubled during 1987-2003, and during that 
period of time the highest recorded incidence rate was 9.7/100 000 (Turunen et 
al., 2006). Similar high incidence rates have been reported in Wisconsin, USA 
(Kugathasan et al., 2003) while in other Western countries the rates remain lower, 
ranging between 4.0 to 7.0 cases per 100 000 (Armitage et al., 2001;Hassan et al., 
2000;Lindberg et al., 2000). According to very recent findings, the incidence of the 
condition is increasing at a rate of 6-8% per year in Finland (Lehtinen et al., 2011). 
The increase in the incidence rate has been reported to be similar for boys and girls 
(Lehtinen et al., 2011). Approximately 15-25% of IBD patients are diagnosed before 
the age of 20 (Kim and Ferry, 2004;Oliva-Hemker and Fiocchi, 2002). The peak 
incidence period of paediatric IBD seems to be around 12-15 years of age (Langholz 
et al., 1997;Turunen et al., 2006). 
The prevalence rates of the disease have also continued to increase worldwide 
as a result of the rising incidence rate, along with improved treatment and survival 
(Loftus and Sandborn, 2002). Currently the prevalence rates of the condition in 
the paediatric population vary greatly between 22-71/100 000 (Hildebrand et al., 
1994;Kappelman et al., 2007). In Finland, according to Social Insurance Institution 
data, about 30 000 individuals in 2007 and over 35 000 individuals in 2010 were 
entitled to medical reimbursement because of IBD. 
1.3. cLinicaL presentation
IBD is characterised by unpredictable exacerbations and remissions. In paediatric 
patients, the clinical presentation of IBD is often more severe compared to adult-
onset disease (Langholz et al., 1997;Nieuwenhuis and Escher, 2008). This difference 
is explained by the distinct anatomic location of inflammation. In paediatric patients 
with Crohn’s disease, inflammation rarely manifests exclusively in the small 
intestine but rather affects the colon, causing symptoms of colitis and thus being 
difficult to distinguish from ulcerative colitis (Auvin et al., 2005;Kugathasan et al., 
2003;Mamula et al., 2003;Turunen et al., 2006). There is also often upper GI tract 
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involvement in paediatric Crohn’s disease (Nieuwenhuis and Escher, 2008). In 
paediatric ulcerative colitis at the time of diagnosis, inflammation is spread wider 
and more frequently affects the whole colon than in adults (in about 61-80% of 
cases) (Griffiths, 2004;Turunen et al., 2006).
Figure 1 illustrates the prevalence of the most common symptoms of Crohn’s 
disease and ulcerative colitis (Figure 1). Generally, growth failure is the first sign 
of the disease in children with early-onset IBD (Stephens et al., 2001). Bone 
demineralisation caused by inadequate nutrition, long-term treatment with 
corticosteroids, and decreased physical activity is a significant problem in paediatric 
patients with Crohn’s disease (Sentongo et al., 2002). Additionally, symptoms of 
IBD may comprise extraintestinal complication such as delayed sexual maturity, 
anaemia, osteoporosis, synovitis/arthritis, skin problems and renal and hepatic 
manifestations (Mamula et al., 2003). Development of malignancies of the affected 
bowel (colon carcinoma) is possible though rare (Brackmann et al., 2009;Zisman 
and Rubin, 2008). The symptoms of IBD are potentially harsh and embarrassing 
and may have a marked influence on the everyday life of adolescents, causing 
psychosocial complications such as depression, social isolation and school absence 
(see the chapter entitled Psychosocial symptoms in paediatric inflammatory bowel 
disease). 
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figure 1. Percentiles of commonly presenting symptoms in children and adolescents at the time of diagnosis 
with paediatric Crohn’s disease (CD) and ulcerative colitis (UC) (adapted from Kugathasan et al., 2003). 
* Data obtained from Langholz et al., 1997. ** Data obtained from Dubinsky, 2008.
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1.4. therapeutic options 
There is no absolute cure for IBD. Therapeutic options in paediatric IBD are 
comparable to those available in adult-onset disease. Treatment focuses on 
controlling the inflammation, minimising symptoms, preventing complications, 
and ensuring as normal physical and psychological growth as possible. Suitable 
treatment depends on the severity of the disease, the location of inflammation 
and the existence of complications. Treatment options are medication, nutritional 
therapy and surgery. Psychosocial aspects of the disease are included in the proper 
care of paediatric IBD.
Table 1 summarises medication guidelines in paediatric patients with mild 
to moderate Crohn’s disease and ulcerative colitis. Additionally, total enteral 
nutrition plays an important role in the treatment of Crohn’s disease (see below). 
Medication of IBD may include 5-aminosalicylate compounds (mesalamine), 
glucocorticoids (corticosteroids), immunomodulators (azathioprine, methotrexate, 
6-mercaptopurine), and biologic treatment (infliximab). Antibiotics that modulate 
the bacterial flora of the bowel (metronidazole, ciprofloxacin) are known to be 
effective, though investigations have failed to prove this successfully (Sartor and 
Muehlbauer, 2007). Medication includes glucocorticoids, mainly when inducing 
remission and the aim is to wean them off as soon as possible due to their undesirable 
side-effects such as emotional changes, sleep disturbance, moon face, weight gain, 
acne, diabetes, hypertension, growth retardation and osteoporosis (McDonough 
et al., 2008). Treatment with corticosteroids has been proven to impair memory, 
executive functions, mood and sleep in paediatric patients with IBD (Mrakotsky et 
al., 2005). Despite this, 45% of paediatric patients with ulcerative colitis (Hyams et 
al., 2006) and 31% with Crohn’s disease (Markowitz et al., 2006) are still dependent 
on corticosteroids one year after diagnosis. Of children with newly diagnosed IBD, 
about 80% had been treated with glucocorticoids within the first 30 days after 
diagnosis (Hyams et al., 2006). In the Finnish cohort, the majority of paediatric 
IBD patients (80%) had been on glucocorticoids at some point, and 76% of them 
received glucocorticoids as a first line treatment at the time of diagnosis (Turunen 
et al., 2009). 
In Crohn’s disease, total enteral nutrition by either elemental or polymeric 
formulas can be used to calm down the inflammation and induce remission (Borrelli 
et al., 2006;Ruuska et al., 1994). In some studies, total enteral nutrition has proved 
to be even more effective compared to corticosteroids in improving the intestinal 
inflammation and maintaining clinical remission (Berni Canani et al., 2006;Ruuska 
et al., 1994). However, opposite findings also exist (Griffiths et al., 1995). Because 
total enteral nutrition has no undesirable side-effects, and it simultaneously corrects 
the chronic malnutrition and mineral deficiency, it should be considered as first 
line treatment in Crohn’s disease when possible (Ruuska et al., 1994).
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table 1. Medication for Crohn’s disease (CD) and ulcerative colitis (UC) in paediatric patients (Adapted 
from Kim and Ferry, 2004).
cd uc
active disease
Mesalamine Oral or rectal for active disease Same
Corticosteroids For active disease Same
Purine analogues (6-MP/AZA) For corticosteroid resistance or 
dependence
Same
Methotrexate For 6-MP/AZA resistance or 
intolerance (less commonly 
used)
Same (but less evidence of 
efficacy)
Anti-TNF-α antibody For corticosteroid resistance, in 
fistulising disease, or to wean 
off corticosteroids
Use unclear but may be 
beneficial
Antibiotics  
(metronidazole/ciprofloxacin)
Beneficial Not beneficial
maintenance therapy
Mesalamine, 6-MP/AZA, 
methotrexate, and anti-TNF-α 
in selected patients
Same (except methotrexate 
and anti-TNF-α)
6-MP, 6-mercaptopurine; AZA, azathioprine; TNF, tumour necrosis factor
Crohn’s disease cannot be cured by surgical resection and, thus, surgery is 
reserved for acute and chronic complications of the disease (such as abscess or 
fistulae formation or stenosis/strictures). Intestinal inflammation in ulcerative colitis 
can be cured with total colectomy, but extraintestinal symptoms may still appear 
and remain. In addition to acute abdominal situations, surgery in ulcerative colitis 
is indicated primarily when medical treatment fails to control the disease, if there is 
evidence of colonic dysplasia or colon carcinoma, if there is severe glucocorticoid-
induced complications or prolonged dependence on them, or in longstanding disease 
(greater than 10 years). In Finland, one-third of all paediatric patients with Crohn’s 
disease and almost a quarter (24%) with ulcerative colitis undergo surgery at some 
point (Turunen et al., 2009). 
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2 Psychosocial symPtoms in Paediatric iBd  
 Patients
The term psychosocial is defined here to involve both mental well-being and social 
aspects of behaviour. Children and adolescents with inflammatory bowel disease 
are required to cope with the disease-related challenges in social surroundings 
as well as the symptoms and medication of the disease, whilst the inflammation 
per se may sway their internal mental well-being and affect their behaviour in 
an unfavourable manner. In this chapter, psychosocial symptoms referring to 
maladaptation, abnormal state of mental health, and ill behaviour in relation to 
the social surroundings among children and adolescents with paediatric IBD are 
reviewed. 
2.1. psychosociaLLy burdensome characteristics  
 of the disease 
Initially, IBD was classified as psychosomatic in origin (Alexander, 1965;Engel, 
1969). Although the exact etiology of IBD remains unknown, increased knowledge of 
the major role of genetic and environmental factors on the pathogenesis of IBD have 
diminished the assumption that psychological factors could be the main cause of the 
disease. Many burdensome characteristics of the disease may, however, predispose 
paediatric IBD patients to psychosocial problems.
IBD symptoms are potentially embarrassing, and the disease course is 
unpredictable and uncertain. This may cause restrictions to social life and impair 
social functioning of these patients (Engström and Lindquist, 1991;Mackner and 
Crandall, 2006). Disease factors such as concerns related to clinical examinations, 
medication and surgery, fear of losing control of the symptoms, and scaring 
malignancies may cause severe psychological stress, which in turn have reported 
to increase the somatic symptoms of the disease, at least in adult studies (Bernstein 
et al., 2010). Emotional and behavioural symptoms may reflect difficulties to adapt 
to lifestyle changes, which are necessary in order to manage with the disease and 
its symptoms, and to possible changes in appearance induced by the disease or its 
treatment (e.g. growth failure, delayed puberty, weight loss, cushingoid features due 
to corticosteroids). Reportedly, patients with IBD are concerned with their body 
image (Karwowski et al., 2009;Maunder et al., 1999). Malabsorption results in 
growth failure and weight loss. It may also lead to a deficiency of certain nutrients 
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that are essential for emotional well-being and neurocognitive functioning such as 
folic acid, B-vitamins and tryptophan (Evers et al., 2010;Obeid et al., 2007;Reynolds 
and Stramentinoli, 1983;Tolmunen et al., 2004).
Corticosteroid treatment, which is frequently used to treat IBD, is known to cause 
emotional lability, euphoria, sleep disturbances, depression, psychotic symptoms, 
and appearance-altering side-effects, such as acne, Cushing’s syndrome, growth 
retardation and delayed puberty (Drigan et al., 1992;Fardet et al., 2007;McDonough 
et al., 2008;Schäcke et al., 2002). In paediatric IBD, treatment with corticosteroids 
associates with increased symptoms of depression; those on steroids had more 
problems with memory and depression compared to those not on steroids 
(Mrakotsky et al., 2005;Szigethy et al., 2004).
Surgery is required when medication fails to control inflammation. More than 
a third of individuals with early-onset IBD will need surgical resection within 20 
years of diagnosis in order to manage the disease (Langholz et al., 1997). This may 
be a huge and frightening step for children, adolescents and their families. However, 
there is evidence that if these patients are well prepared and receive appropriate 
aftercare, abdominal surgery does not impair the psychological adjustment, self-
esteem or quality of life of these children (Lask et al., 1987); indeed, quality of life 
may even improve permanently (Lillehei et al., 2010;Tulchinsky et al., 2010). 
2.2. parent and seLf-reported psychosociaL  
 symptoms 
Until now, psychosocial problems have been well studied among the adult 
population of IBD patients. Adults with IBD are more likely to have psychiatric 
diagnosis (most commonly depression or anxiety) than healthy adults (Graff et 
al., 2009;Mikocka-Walus et al., 2007). In recent years, knowledge of psychosocial 
symptoms among paediatric IBD patients has also greatly increased. Psychosocial 
symptoms in paediatric IBD have mainly been assessed in the United States 
(Burke et al., 1989;Burke et al., 1994b;Mackner and Crandall, 2005;Mackner and 
Crandall, 2006;Szajnberg et al., 1993;Szigethy et al., 2004;Wood et al., 1987) but 
also in Germany (Steinhausen and Kies, 1982), Sweden (Engström and Lindquist, 
1991;Engström, 1992;Engström, 1999;Lindfred et al., 2008), Great Britain (Moody 
et al., 1999), Canada (Gold et al., 2000), and the Netherlands (De Boer et al., 2005)
(Table 2). According to these studies, children and adolescents with IBD seem to 
be at greater risk of difficulties in emotional and behavioural functioning as well 
as social and family functioning compared to their peers in the normal population 
(Engström and Lindquist, 1991;Wood et al., 1987). When these psychosocial issues 
are compared to other groups of chronically ill children and adolescents, the findings 
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table 2. Review of studies concerning psychosocial symptoms among children and adolescents with paediatric IBD.
iBd patients controls study question methods and respondents main results
n age (y) n
Steinhausen H. 
(1982)
17 mean 13.0 17 Healthy Psychopathology; Severity of IBD 
included
I: parent 
Q: parent, child
More psychiatric (mainly emotional) disorders in IBD group than in 
controls (59% vs. 18%); No association between disease variables and 
psychopathology.
Wood B. (1987) 88 6-17 65 Siblings Psychological functioning; Severity of IBD 
included
Q: parent (CBCL),
child (HPC)
More psychological (mainly emotional) dysfunction in IBD group than in 
siblings; No correlation between CBCL scores and disease variables. 
Burke P. (1989) 55 mean 12.1 52 Cystic fibrosis 
(CF)
Prevalence of lifetime/current depression 
and anxiety disorders
I: child (K-SADS) Lifetime prevalence of depression was higher in IBD (25%) than in CF 
(12%); No group difference in current depressive or lifetime/current anxiety 
disorders.
Burke P. (1990) 13 mean 12.3 - - Depression in newly diagnosed IBD; 
Severity of IBD included
I: parent (A-SADS-L), child 
(K-SADS-E)
Q: parent (FRI, FILE)
The depressed children (n=3) had less severe symptoms of IBD than non-
depressed counterparts (n=10), and they had not needed steroids. 
Engström I.
(1991)
20 9-18 20 Healthy Prevalence of psychiatric disorder; 
Severity of IBD included
I: child (CAS)
Q: parent (CBCL)
More children with IBD had psychiatric diagnosis (60%) than controls (15%) 
(mainly depressive and anxiety). Higher Total, Internalising and Externalising 
CBCL scores and lower social competence scores in patients than in controls. 
No correlation to disease severity.
Engström I. 
(1992)
20 9-18 20/ 
each
Healthy, diabetes, 
headache
Psychological functioning I: child (CAS)
Q: parent (e.g. CBCL), child 
(e.g. CDI)
IBD patients had lower self-esteem, social competence, and general well-
being, and higher CDI scores than healthy controls. Overall, more psychiatric 
disturbances in IBD group than in other disease groups. No difference on 
anxiety. 
Szajnberg N. 
(1993)
15 mean 11.6 - - Psychopathology and relationship issues 
in newly diagnosed IBD
I: parent (AAI), child 
(K-SADS)
Q: parent (e.g. MCMI, CBCL)
Psychological tests: child 
73% of children had DSM-III diagnosis (internalising). 78% of parents had 
DSM-III diagnosis (personality disorder). CBCL revealed more Internalising 
than Externalising problems in children. Psychological test revealed 
constriction, anxiety, denial and depression in children with IBD. Three 
children were suicidal. Thirteen mothers were insecurely attached to their 
children.
Burke P. (1994) 36 mean 12.0 - - Prevalence of depression and anxiety 
disorders in newly diagnosed IBD; 
Severity of IBD included
I: parent (A-SADS-L), child 
(K-SADS)
Q: parent, child
14% (n=5) had major depression and 28% (n=10) had depressive symptoms, 
only 1 had symptoms before onset of IBD. 28% (n=10) had anxiety disorder, 8 
had symptoms before onset. Less severe illness, maternal lifetime depression, 
stressful life events and family dysfunction associated with depression.  
Engström I. 
(1999)
20 9-18 20/ 
each
Healthy, diabetes, 
headache
Psychological functioning, self-esteem 
and family functioning; Severity of IBD 
included
I: parent, child (CAS)
Q: parent (e.g. CBCL), child 
(e.g. CDI)
IBD group had higher levels of maternal distress and greater family 
dysfunction than healthy controls. No significant differences between disease 
groups. Self-esteem was lowered in IBD. No correlation between severity of 
IBD and psychiatric symptoms. 
Gold N. (2000) 36 8-18 26 Functional 
gastrointestinal 
(FGI) complaints 
Psychosocial functioning Q: parent (CBCL), child 
(CDI, PH)
IBD patients were less depressed, had fewer behavioural problems, and 
higher self-esteem than FGI patients. In IBD group, 19% thought their illness 
as problem to them (vs. 65% in FGI group)
Szigethy E. 
(2004)
102 11-17 - - Prevalence of depressive symptoms; 
Severity of IBD included
I:child (K-SADS-PL)
Q: child (CDI)
25% had clinically significant CDI scores. Children with moderate/severe 
IBD symptoms had higher mean CDI scores than those with mild disease 
symptoms. Patients on steroids were more likely to have clinically significant 
CDI scores than those not on steroids. 
De Boer M. 
(2005)
40 12-18 18 Healthy Self-esteem and HRQoL. Q: parent (e.g. CBCL), child 
(e.g. DUCATQOL)
IBD patients have worse HRQoL and more Internalising problems than healthy 
controls. Self-esteem predicts HRQoL.
Mackner LM. 
(2005)
50 11-17 42 Healthy Psychosocial functioning, self-esteem; 
Severity of IBD included
Q: child (e.g. YSR, PH),
gastroenterologist (PCDAI)
No group difference on any of the measures. 20% in IBD group had clinically 
significant behavioural/emotional symptoms. Severity of the disease did not 
correlate with psychosocial symptoms.
Mackner LM. 
(2006)
50 mean 14.4 42 Healthy Psychosocial and  family functioning; 
Severity of IBD included
Q: parent (CBCL, FAD), 
gastroenterologist (PCDAI)
Adolescents with IBD had more anxious/depression and social impairment 
than controls. Severity of the disease did not correlate with psychosocial 
symptoms.
Lindfred H. 
(2008)
71 10-16 1037 Healthy Self-esteem; Severity of IBD included Q: child (ITIA) Self-esteem was similar in both groups. Children with severe IBD symptoms 
and separated parents had higher risk for problems with self-esteem.
I/Q= Interview and/or questionnaire based study; y= years; CBCL= Child Behavior Checklist; HPC= Harter’s 
Perceived Competence Scale for Children; K-SADS= Kiddie Schedule for Affective Disorders and Schizophrenia; 
CAS= Child Assessment Schedule; CDI= The Children’s Depression Inventory; FAD= Family Assessment Device; 
PCDAI= Paediatric Crohn Disease Activity Index; ITIA = I think I am; MCMI= Million Clinical Multi-Axial Inventory; 
YSR= Youth Self-Report; K-SADS-PL= Schedule for Affective Disorders and Schizophrenia for School-Age 
Children – Present and Lifetime Version; K-SADS-E=Kiddie Schedule for Affective Disorders and Schizophrenia 
- Epidemiologic Version; PH= Piers-Harris Test of Self-Concept ; A-SADS-L= Adult Schedule for Affective 
Disorders and Schizophrenia – Life-time Version; AAI= Adult Attachment Interview; FRI=Family Relationship 
Index Scale; FILE=Family Inventory of Life events; DUCATQOL=Dutch Children’s Quality of Life Questionnaire
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More psychological (mainly emotional) dysfunction in IBD group than in 
siblings; No correlation between CBCL scores and disease variables. 
Burke P. (1989) 55 mean 12.1 52 Cystic fibrosis 
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Prevalence of lifetime/current depression 
and anxiety disorders
I: child (K-SADS) Lifetime prevalence of depression was higher in IBD (25%) than in CF 
(12%); No group difference in current depressive or lifetime/current anxiety 
disorders.
Burke P. (1990) 13 mean 12.3 - - Depression in newly diagnosed IBD; 
Severity of IBD included
I: parent (A-SADS-L), child 
(K-SADS-E)
Q: parent (FRI, FILE)
The depressed children (n=3) had less severe symptoms of IBD than non-
depressed counterparts (n=10), and they had not needed steroids. 
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(1991)
20 9-18 20 Healthy Prevalence of psychiatric disorder; 
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I: child (CAS)
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(mainly depressive and anxiety). Higher Total, Internalising and Externalising 
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disturbances in IBD group than in other disease groups. No difference on 
anxiety. 
Szajnberg N. 
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in newly diagnosed IBD
I: parent (AAI), child 
(K-SADS)
Q: parent (e.g. MCMI, CBCL)
Psychological tests: child 
73% of children had DSM-III diagnosis (internalising). 78% of parents had 
DSM-III diagnosis (personality disorder). CBCL revealed more Internalising 
than Externalising problems in children. Psychological test revealed 
constriction, anxiety, denial and depression in children with IBD. Three 
children were suicidal. Thirteen mothers were insecurely attached to their 
children.
Burke P. (1994) 36 mean 12.0 - - Prevalence of depression and anxiety 
disorders in newly diagnosed IBD; 
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stressful life events and family dysfunction associated with depression.  
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Psychological functioning, self-esteem 
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included
I: parent, child (CAS)
Q: parent (e.g. CBCL), child 
(e.g. CDI)
IBD group had higher levels of maternal distress and greater family 
dysfunction than healthy controls. No significant differences between disease 
groups. Self-esteem was lowered in IBD. No correlation between severity of 
IBD and psychiatric symptoms. 
Gold N. (2000) 36 8-18 26 Functional 
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(FGI) complaints 
Psychosocial functioning Q: parent (CBCL), child 
(CDI, PH)
IBD patients were less depressed, had fewer behavioural problems, and 
higher self-esteem than FGI patients. In IBD group, 19% thought their illness 
as problem to them (vs. 65% in FGI group)
Szigethy E. 
(2004)
102 11-17 - - Prevalence of depressive symptoms; 
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I:child (K-SADS-PL)
Q: child (CDI)
25% had clinically significant CDI scores. Children with moderate/severe 
IBD symptoms had higher mean CDI scores than those with mild disease 
symptoms. Patients on steroids were more likely to have clinically significant 
CDI scores than those not on steroids. 
De Boer M. 
(2005)
40 12-18 18 Healthy Self-esteem and HRQoL. Q: parent (e.g. CBCL), child 
(e.g. DUCATQOL)
IBD patients have worse HRQoL and more Internalising problems than healthy 
controls. Self-esteem predicts HRQoL.
Mackner LM. 
(2005)
50 11-17 42 Healthy Psychosocial functioning, self-esteem; 
Severity of IBD included
Q: child (e.g. YSR, PH),
gastroenterologist (PCDAI)
No group difference on any of the measures. 20% in IBD group had clinically 
significant behavioural/emotional symptoms. Severity of the disease did not 
correlate with psychosocial symptoms.
Mackner LM. 
(2006)
50 mean 14.4 42 Healthy Psychosocial and  family functioning; 
Severity of IBD included
Q: parent (CBCL, FAD), 
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Adolescents with IBD had more anxious/depression and social impairment 
than controls. Severity of the disease did not correlate with psychosocial 
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71 10-16 1037 Healthy Self-esteem; Severity of IBD included Q: child (ITIA) Self-esteem was similar in both groups. Children with severe IBD symptoms 
and separated parents had higher risk for problems with self-esteem.
24
Review of the literature 
are inconsistent (Burke et al., 1989;Engström, 1992;Gold et al., 2000). Paediatric 
IBD patients seem to present less with depression than their peers with functional 
gastrointestinal complaints (Gold et al., 2000) but they seem to experience more 
psychosocial impairment than their counterparts with cystic fibrosis (Burke et 
al., 1989) or diabetes (Engström, 1992). Mackner LM et al. (2004) reviewed the 
existing studies in this field and stated that overall they are characterised by poor 
methodology (Mackner et al., 2004). Sample sizes are small, unspecified and 
unpublished questionnaires are used, and when standardised measures are used, 
T-scores are not necessarily reported (e.g. Engström and Lindquist, 1991;Engström, 
1992) limiting evaluation of clinical significance and comparison to other parallel 
studies (Mackner et al., 2004). Furthermore, methods to define disease symptom 
severity vary greatly between earlier studies, and in many of them the disease 
severity has not been included at all (Table 2). Additionally, all the Swedish studies of 
Engström I (1991, 1992, 1999) seem to be based on the same sample of IBD children 
and controls (Engström and Lindquist, 1991;Engström, 1992;Engström, 1999). 
2.2.1.  behaviouraL and emotionaL functioning in patients with  
 paediatric ibd 
Prevalence of psychiatric disorders have been assessed in a few studies based on 
structured (e.g. CAS) or semi-structured (e.g. K-SADS, AAI) interviews (Burke et al., 
1989;Burke et al., 1994b;Engström, 1992;Szajnberg et al., 1993;Szigethy et al., 2004) 
(Table 2). Of these, only Burke P et al. (1989) and Szigethy E et al. (2004) describe 
interviewer training or reliability checks, which are essential for the reliable usage 
of these instruments. Engström I et al. (1991, 1992, 1999) utilised the structured 
interviews of the Child Assessment Schedule (CAS) and found that significantly 
more of the 20 children with IBD (60%) had a psychiatric disorder, particularly 
serious depressive and anxiety disorders, than controls with headaches (30%) or 
diabetes (20%), or healthy controls (15%) (Engström, 1992). Steinhausen H et al. 
(1982) used an unspecified interview and reported similar frequencies (59%) of 
psychiatric diagnosis among children with IBD (n=17) according to the International 
Classification of Diseases, Ninth Edition (ICD-9) (Steinhausen and Kies, 1982). The 
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) revealed that 
73% (n=11) of children with IBD met the criteria for DSM-III psychiatric diagnosis, 
mainly internalising disorders (Szajnberg et al., 1993). More recently, Szigethy et 
al. (2004) used both questionnaire (Children’s Depression Inventory, CDI) and 
interview (K-SADS-PL) measures to investigate the prevalence of depressive 
symptoms among adolescents with IBD (n=102). One-quarter (n=25, 25%) of 
them had clinically significant depressive symptom scores on the CDI. Of these 25 
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adolescents, 19 participated in the interview and of those, 16 met the criteria for 
diagnosable major or minor depressive disorder (Szigethy et al., 2004). There was 
no control group included (Szigethy et al., 2004) (Table 2).
Burke P et al. (1989) used K-SADS in order to compare anxiety and depressive 
disorders between children with IBD (n=55) and children with cystic fibrosis (CF; 
n=52) (Burke et al., 1989). The lifetime prevalence of depressive disorder was higher 
among IBD (25%) than CF patients (12%) but there was no group difference in 
the current prevalence of depression (10% in IBD), or in the lifetime or current 
prevalence of anxiety disorders (11% and 4% in IBD, respectively) (Burke et al., 
1989). A few years later Burke P et al. (1994) studied the same issue in a different 
sample of 36 newly diagnosed children with IBD, though this time without a control 
group, and found that 14% (n=5) of the sample met the criteria for major depression, 
28% (n=10) had depressive symptoms, and 28% (n=10) met the criteria for anxiety 
disorder (Burke et al., 1994b) (Table 2). The study subjects did not have a history 
of depression before the onset of the disease and thus the results suggest that 
depressive symptoms and disorders arise after IBD diagnosis (Burke et al., 1994b).
Several studies used standardised questionnaires for parents (e.g. CBCL) and 
children (e.g. CDI) (Table 2). In four studies, the mean normative T-scores fell 
within the normal range (Gold et al., 2000;Mackner and Crandall, 2005;Mackner 
and Crandall, 2006;Wood et al., 1987). Wood B et al. (1987) found that average 
CBCL scores for total and internalising symptoms were significantly higher in 
children with IBD than their siblings, and 39% of CD and 29% of CU patients had 
clinically significant CBCL scores for total problems (respective values in siblings 
were 24% and 4%) (Wood et al., 1987). Gold N et al. (2000) found that children with 
IBD (n=36) had fewer symptoms of CBCL and CDI than children with functional 
gastrointestinal complaints (n=26) and therefore concludes that for paediatric 
IBD patients, achieving normal psychosocial adjustment is possible (Gold et al., 
2000). Mackner LM et al. (2005) found no significant difference between IBD 
adolescents and their healthy peers on any of the self-assessments used (Mackner 
and Crandall, 2005). However, a subset of IBD adolescents (20%) reported clinically 
significant emotional/behavioural symptoms but the frequency did not differ from 
that in control adolescents (31%) (Mackner and Crandall, 2005). Most of the IBD 
adolescents were in remission or the disease symptoms were mild at the time of the 
study, and the disease was diagnosed at least one year earlier. According to parental 
reports on the CBCL, adolescents with IBD had more anxiety, depression, and 
social impairment than healthy control adolescents (Mackner and Crandall, 2006). 
Three studies using the same sample of 20 children with IBD, and controls of 
healthy children and children with diabetes and headaches (n=20 in each control 
group) report that children with IBD had significantly higher total and internalising 
scores on the CBCL, and in self-report (e.g. CDI) they expressed significantly more 
depressive symptoms than the healthy children did (Engström and Lindquist, 
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1991;Engström, 1992;Engström, 1999) (Table 2). No significant difference emerged 
between children with IBD and healthy children in self-reported anxiety symptoms, 
and only few significant differences were documented between the illness groups, for 
example anxiety levels was significantly higher in the headache group than in other 
comparison groups and IBD patients scored significantly higher in a lie scale than 
the other groups (Engström and Lindquist, 1991;Engström, 1992;Engström, 1999). 
Furthermore, IBD patients had significantly more parent-reported behavioural 
problems (Engström and Lindquist, 1991) and their self-esteem was lower compared 
to healthy controls (Engström, 1992).
2.2.2. sociaL and schooL functioning in patients with paediatric ibd
A study assessing social and school life of children with IBD reports that 60% of 
IBD subjects (n=64) had prolonged absences from school with a mean of three 
months over the previous 12 months, 80% reported that their success in school was 
lowered due to the disease, and their social life including playing outside with friends, 
taking part in sports, and staying overnight at a friend’s house was reduced and 
restricted (Moody et al., 1999) (Table 3). According to the CBCL social competence 
scale, IBD patients had significantly lower social competence than their healthy 
peers (Engström and Lindquist, 1991;Engström, 1992) and they also had a lower 
score on this scale compared to controls with diabetes or headaches (Engström, 
1992). However, in these studies T-scores were lacking, making evaluation of clinical 
significance impossible. According to Mackner LM et al. (2006), parents reported 
on the CBCL that children with IBD had significantly worse social competence than 
healthy children (Mackner and Crandall, 2006), but children themselves did not 
confirm this finding on the YSR (Mackner and Crandall, 2005) (Table 3). Gold et al. 
(2000) reported that the mean CBCL Social Competence T-score among children 
with IBD (n=36) was similar compared to controls with functional gastrointestinal 
complaints and fell within the normal range, indicating adequate social functioning 
in these children (Gold et al., 2000). One study of health-related quality of life 
(HRQoL) in eight paediatric conditions (obesity, eosinophilic gastrointestinal 
disorder, IBD, epilepsy, type 1 diabetes, sickle cell disease, post-renal transplantation 
and cystic fibrosis) reports that there were no significant group differences between 
the IBD group and the other disease groups in self-reported HRQoL, including the 
domains of physical, emotional, social, school and psychosocial (Ingerski et al., 
2010). According to the parental report, HRQoL in the IBD group was either similar 
or significantly better in all previously mentioned domains, including social and 
school functioning than in the other illness groups (Ingerski et al., 2010) (Table 3).
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2.2.3. famiLy psychiatric history and famiLy functioning
Chronic illness of a child influences other family members and family functioning. 
Family functioning and psychosocial symptoms of the parents and siblings have 
also been studied in families with a child suffering from IBD. Conflicting results 
exist between families with a child with IBD and comparison families with healthy 
children. Engström I et al. (1999) found that mothers reported greater family 
dysfunction in families with a child with IBD than in control families with a healthy 
child or a child with diabetes (Engström, 1999). Mackner LM et al. (2006) in turn 
found no difference in family functioning between families with a child with IBD 
or a healthy child (Mackner and Crandall, 2006). In families with a child with 
IBD, family dysfunction significantly relates to increased severity of the disease, a 
greater number of symptoms of pain/fatigue, more bowel movements and a higher 
prevalence of emotional and behavioural symptoms (Burke et al., 1990;Tojek et al., 
2002;Wood et al., 1989). Within IBD families, family-wide stress, communication 
styles, and agreement rate regarding the disease factors are related to the activity 
of the child’s IBD, and a patient’s individual stress relates to his/her overall coping 
with the disease (Gerson et al., 1998). 
A study of 13 newly diagnosed paediatric IBD patients found that six of these 
patients’ mothers had a history of depression, and the mothers of all three depressed 
children had a history of depression (Burke et al., 1990). Furthermore, the mothers 
of depressed children reported a lack of cohesion and high conflict rates in their 
families (Burke et al., 1990;Burke et al., 1994a). Another study found that the 
prevalence of current (10%) and lifetime diagnosis (51%) of maternal depression 
assessed by A-SADS interview was similar in mothers of children with IBD than 
those of cystic fibrosis (Burke et al., 1994a). Engström I et al. (1999) found that 
mothers of children with IBD reported more emotional and behavioural symptoms 
relating to themselves than mothers of healthy children (Engström, 1999). Mothers 
of IBD children also suffered from higher parental distress than mothers of healthy 
children but, in this respect, the fathers did not differ from the comparison fathers 
(Engström, 1991).
2.3. reLationship between psychoLogicaL factors and 
disease severity 
Psychological factors including anxiety, depression and experienced stress seem to 
cause disease exacerbations in adult IBD patients (Graff et al., 2009;Maunder and 
Levenstein, 2008;Mawdsley and Rampton, 2006;Mawdsley et al., 2006). Symptoms 
of IBD are more severe in depressed adults with IBD than in their non-depressed 
counterparts (Graff et al., 2009). So far, the studies on the relationship between 
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have reported inconsistent results (Burke et al., 1994b;Engström and Lindquist, 
1991;Mackner and Crandall, 2005;Steinhausen and Kies, 1982;Szigethy et al., 
2004;Wood et al., 1987). 
Of the disease variables including duration of IBD, histological and radiological 
findings, frequency of relapses and growth retardation, only the last showed 
significant association with disturbed psychological functioning in adolescents with 
IBD (Steinhausen and Kies, 1982). In another study, psychological functioning 
did not relate to any of the disease variables that included disease activity, disease 
severity, duration of the disease, and growth failure (Wood et al., 1987). However, 
according to that study, an internalising psychological style (referring to the way 
in which psychological problems are expressed and solved) associated with greater 
disease activity, and self-perceived severity of IBD correlated negatively with self-
rated physical and social competence (Wood et al., 1987). One study reports more 
depressive symptoms in those paediatric IBD patients who suffer from moderate/
severe disease symptoms than those with inactive disease (Szigethy et al., 2004). 
Furthermore, in that study usage of steroids was associated with a clinically 
significant rate of emotional symptoms (Szigethy et al., 2004). Risk of impaired 
self-esteem is elevated in young people with severe IBD symptoms (Lindfred et 
al., 2008). Interestingly, depressed paediatric IBD patients have also reported to 
have less severe IBD symptoms than their non-depressed counterparts (Burke et 
al., 1990;Burke et al., 1994b). One study recognised a subgroup of children and 
adolescents with good mental health and psychosocial outcomes despite severe 
IBD symptoms (Engström, 1999). These children and adolescents had common 
characteristics such as good knowledge of the disease and a willingness to learn more 
about it, ability to name factors (commonly stressful factors) that could increase 
IBD symptoms, belief of being able to influence the disease course themselves 
to a certain extent, and an open and permissive climate in the family and a well-
functioning social network (Engström, 1999). Interestingly, negative affectivity 
associates significantly with subjective perception of IBD disease severity rather than 
with objectively determined (laboratory values) severity of the disease (Ondersma 
et al., 1997).
In inflammatory bowel disease, the relationship between psychological 
symptoms and disease severity seems to be bidirectional. Somatic symptoms of 
the disease, treatment and other disease-related concerns may cause stress and 
increase the risk of depression and anxiety among these patients (see the previous 
chapter). Psychological factors, such as stress and emotional problems, have an 
impact on systemic and local immune functions (Daruna and Morgan, 1990) and 
may, in turn, worsen the somatic symptoms of the disease, which have been well 
demonstrated among adult IBD patients (Bernstein et al., 2010;Levenstein et al., 
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2000). Experienced stress may also decrease the threshold for the perception of 
pain leading to subjective perceptions of more severe disease (Gonlachanvit et al., 
2005;Murray et al., 2004). In animal models of colitis, acute psychological stress 
can result in objectively measured initiation and reactivation of colitis (Collins et 
al., 1996;Gué et al., 1997). Thus, a vicious circle is created: the symptoms of IBD 
may cause psychosocial stress and stress, in turn, may worsen the symptoms of the 
disease. The brain-gut axis (Figure 2), which operates through hormones between 
the hypothalamus, pituitary gland, adrenal gland, and enteric nervous system 
(ENS), is hypothesised to form a linkage between psychological factors and the 
abdominal symptoms in IBD (Hisamatsu et al., 2007). Further introduction of this 
hypothetical physiological interaction between the functions of the bowel and the 
brain is unfortunately beyond the scope of this study.
figure 2. Brain-gut axis. CRF, corticotrophin-releasing factor; ACTH, adrenocorticotropic hormone; 
ENS, enteric nervous system (adapted from Hisamatsu et al., 2007; Mawdsley and Rampton, 
2005)
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3 agreement on Psychosocial symPtoms  
 Between adolescents and their Parents
Evaluation of a child’s psychosocial and somatic symptoms generally relies on the 
information gathered from both the parents and the children/adolescents themselves 
through clinical interviews or questionnaire-based methods in addition to clinical 
observation performed by health care workers. Screening questionnaires are often 
used in clinical practice since they are time and cost-effective methods for receiving 
necessary information (Fombonne, 1991). Disagreement between the respondents 
is expected due to generational conflicts and different viewpoints, and does not 
necessarily imply that the information received from one or both respondents is 
incorrect. Disagreement exists even when the questionnaires are comparable and 
validated for parents and adolescents (Salbach-Andrae et al., 2009a;Sourander et 
al., 1999). A low correlation rate (r=0.22) on emotional and behavioural symptoms 
between child and parent informants has been shown in a meta-analysis (Achenbach 
et al., 1987), and has since been replicated in paediatric psychiatric patients and 
in the general population (Ferdinand et al., 2006;Kolko and Kazdin, 1993;Rothen 
et al., 2009;Salbach-Andrae et al., 2009a;Sourander et al., 1999). It is suggested 
that disagreement on psychosocial symptoms between adolescents and their 
parents predicts a risk of unwanted outcomes of the adolescents, such as drug 
and tobacco use, police contact, expulsion from school or being sacked from a job, 
unwanted pregnancy, intentional self-harm, need for professional help, referral to 
mental health services, and reports of suffering from behavioural and/or emotional 
difficulties (Ferdinand et al., 2004).
In clinical, mainly psychiatric, settings, the parents have a tendency to attribute 
more emotional and behavioural problems to adolescents than adolescents do to 
themselves (Kazdin et al., 1983;Phares and Danforth, 1994;Salbach-Andrae et 
al., 2009a;Thurber and Osborn, 1993). In non-psychiatric study populations the 
opposite occurs (Rothen et al., 2009;Seiffge-Krenke and Kollmar, 1998;Sourander 
et al., 1999;Stanger et al., 1993;Vassi et al., 2008;Verhulst and van der Ende, 
1992;Waters et al., 2003). It is suggested that both in clinical and normal 
populations, a higher parent-adolescents agreement rate prevails with behavioural 
than emotional problems (Cantwell et al., 1997;Kolko and Kazdin, 1993;Salbach-
Andrae et al., 2009a;Sourander et al., 1999) since the parents are more able to report 
such symptoms that are visible and can be “seen” (behavioural problems) compared 
to hidden emotions (Vassi et al., 2008). However, the opposite results also exist 
(Seiffge-Krenke and Kollmar, 1998;Verhulst and van der Ende, 1992). Mothers are 
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often more capable of sensing their child’s problems and, thus, according to the 
literature, greater agreement prevails between mother and child than father and 
child (Seiffge-Krenke and Kollmar, 1998;Vassi et al., 2008).
The degree of agreement can be considered to indirectly reflect the quality aspects 
of the parent-child relationship and mutual comprehension. Investigations have 
recognised several parent and child-associated factors that influence the degree of 
parent-adolescent agreement: child’s age (Berg-Nielsen et al., 2003;Verhulst and 
van der Ende, 1992) and gender (Sourander et al., 1999;Verhulst and van der Ende, 
1992;Waters et al., 2003); parental psychological status and stress (Berg-Nielsen 
et al., 2003;Martin et al., 2004;Seiffge-Krenke and Kollmar, 1998;Treutler and 
Epkins, 2003); family connectedness (Duke et al., 2005); mother’s satisfaction 
with marriage (Seiffge-Krenke and Kollmar, 1998); child’s school performance 
(Waters et al., 2003); socio-economic status of the family (Treutler and Epkins, 
2003); parents’ alcohol drinking (Duke et al., 2005), profession (Luoma et al., 
2004;Treutler and Epkins, 2003), and education (Luoma et al., 2004). For example, 
parent-adolescent disagreement was more likely to occur if the adolescent had good 
academic performance, or was dissatisfied due to his/her self-image or life; if the 
parents had a low education level or were unaware of their child’s leisure activities; 
or if the mother was depressed (Vassi et al., 2008). The direction of influence of 
the above-mentioned factors may be conflicting. For instance, some studies suggest 
that the older age of the child associates with a higher degree of agreement between 
parent and child (Berg-Nielsen et al., 2003), while others suggest the opposite 
(Achenbach et al., 1987;Verhulst and van der Ende, 1992). 
The existing studies used various statistical methods to measure degree 
of agreement, thus, the results are not necessarily comparable (e.g. Pearson’s 
correlation coefficient (Sourander et al., 1999), intra-class coefficient (Salbach-
Andrae et al., 2009a), and kappa (Martin et al., 2004)). Earlier, this issue has been 
studied mainly in normal and psychiatric populations. Studies assessing agreement 
on psychosocial symptoms between adolescents with chronic somatic disease and 
their parents are so far greatly lacking.
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4 sleeP ProBlems and daytime tiredness  
 in Paediatric iBd
Sleep problems are common and often chronic among adolescents (Roberts et 
al., 2008a). In the community, up to 25% of children and adolescents suffer from 
disturbed sleep (Liu et al., 2005;Owens, 2008) and approximately 10% have 
significant problems with daytime tiredness (Owens et al., 2000). Among patients 
with paediatric somatic disease or psychiatric disorder, sleep problems are even 
more common (Bandla and Splaingard, 2004;Ivanenko et al., 2004b;Ivanenko et 
al., 2006;Ivanenko and Gururaj, 2009;Owens, 2008). In the community, children 
tend to identify and report more sleep disturbances themselves than their parents 
do (Owens et al., 2000).
In children and adolescents, sleep problems can be broadly defined and may 
include both primarily medical and biologically-based problems (e.g. obstructive 
sleep apnoea and parasomnias) and more behaviour-based disorders such as 
bedtime resistance (Ivanenko and Gururaj, 2009;Owens, 2008). Sleep trouble can 
be present in various forms such as difficulty falling asleep, difficulty maintaining 
asleep, poor sleep quality, waking up too early, or increased daytime tiredness. Sleep 
disturbances can be measured either by objective (polysomnography, actigraphy) 
or subjective (questionnaire, interview) methods or, in paediatric patients they can 
be rated by parents. 
Comprehensive studies on the frequency of sleep disturbances and associating 
psychosocial symptoms in young patients with IBD are so far lacking. Only one 
preliminary study concerning sleep disturbances among adolescents with IBD 
(n=41) in Israel, published as an abstract, exists (Nachmias et al., 2006). In that 
study, a Mini-Sleep Questionnaire was utilised to detect sleep disturbances and 
daytime tiredness among adolescents with IBD. Half of the patients (n=22, 54%) 
had disturbed sleep. Morning fatigue on waking (76%), sleep interruption (54%) 
and chronic unexplained fatigue (39%) were the most common types of sleep 
disturbances (Nachmias et al., 2006). Sleep disturbance did not correlate with 
disease characteristics of IBD (disease type, activity, medical treatment), or age 
and gender of the patients. No precise information was given about the method 
of collecting data on sleep or disease activity, and a control group was lacking. 
Presumably, the questionnaire was self-completed but actually the respondent is 
not clearly stated in the abstract text (Nachmias et al., 2006). 
The following paragraphs review studies concerning sleep disturbances among 
adult patients with IBD, and introduce the relationship between sleep disturbances, 
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and somatic health problems and inflammation status. Studies concerning sleep in 
paediatric patients who suffer from another chronic inflammatory condition, juvenile 
idiopathic arthritis (JIA), are also reviewed here. At the end of this chapter, the 
researcher introduces psychosocial symptoms that associate with sleep disturbances 
in the paediatric population. 
4.1. sLeep probLems in aduLt patients with ibd
Three studies have investigated quality of sleep and/or daytime tiredness in adult 
IBD patients (Keefer et al., 2006;Ranjbaran et al., 2007a;Zimmerman, 2003). The 
first of them focused on extraintestinal symptoms, including sleep disturbances, in 
adult IBD patients (n=55) compared to patients with irritable bowel syndrome (IBS) 
(n=53) and healthy controls (n=56) (Zimmerman, 2003). That study included only 
males. The extraintestinal symptoms were assessed using a validated, self-reported 
questionnaire grading the intensity of various somatic symptoms on a 5-point scale 
(the Multisystem Inventory). The results revealed that both IBD (p=0.004) and 
IBS patients (p=0.041) suffered from sleep disturbances significantly more often 
than the controls, and that diarrhoea predicted sleep disturbances in IBD patients 
(Zimmerman, 2003).
The first comprehensive study on sleep disturbances in IBD examined sleep 
problems in adult patients with inactive IBD (n=16) by several questionnaires and 
one-night polysomnography (PSG), and compared the results with those of IBS 
patients (n=9) and healthy controls (n=7) (Keefer et al., 2006). Patients with IBD 
did not significantly differ from patients with IBS with respect to subjectively and 
objectively measured sleep parameters. However, the perceived sleep quality of 
both patient groups was lower than in the control group. Furthermore, the three 
groups did not differ with respect to daytime dysfunction or daytime tiredness 
(Keefer et al., 2006). As many as 64% (n=9) of the IBD patients stated that poor 
sleep led to intestinal symptoms and, 43% (n=5) described GI symptoms leading 
to poor sleep (Keefer et al., 2006). That study assessed quality of life in addition to 
sleep variables, and found that the quality of life and sleep were impaired in IBD 
patients although their disease was in remission (Keefer et al., 2006). The study 
was limited by small sample size.
Another questionnaire-based study of sleep disturbances among adult patients 
with inactive IBD (n= 80) as compared to patients with IBS (n=24) and controls 
(n=15) replicates the earlier findings (Ranjbaran et al., 2007a). The study showed that 
the IBD subjects suffer more frequently from prolonged sleep latency, fragmented 
sleep, decreased daytime energy, and increased tiredness, that they use sleeping 
pills at a higher rate, and that their overall sleep quality is impaired compared to 
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healthy controls (Ranjbaran et al., 2007a). The IBD and IBS groups were similar 
in respect of abnormal sleep patterns. Of the IBD patients, 71% complained of 
interrupted sleep and night-time awakenings more than once or twice per week, 
while the figure was only 40% in controls (p=0.02). Patients with IBD had many 
reasons for sleep interruption: abdominal pain, need to use the bathroom, breathing 
difficulty, snoring, feeling too cold or too hot, and nightmares (Ranjbaran et al., 
2007a). In IBD, 23% reported waking up due to anxiety and concerns about their 
disease (Ranjbaran et al., 2007a). 
4.2.  sLeep probLems in reLation to severity of  
 infLammatory disease and somatic heaLth  
 probLems 
4.2.1 sLeep, immune system, and severity of infLammation
Several studies show bidirectional associations between sleep and the immune 
system (Palma et al., 2007;Rogers et al., 2001). Activation of the immune system 
modulates the sleep-wake cycle and changes the sleep architecture (Born et 
al., 1997;Dinges et al., 1994;Lange et al., 2010). It is suggested that immuno-
endocrine factors, e.g. circulating inflammatory cytokines and hormones related 
to hypothalamic-pituitary-adrenal (HPA) axis, mediate these changes (Ranjbaran 
et al., 2007b). Conversely, sleep deprivation, which is considered a stressor, may 
affect the immune system function, altering and reinforcing the inflammation 
process (Ranjbaran et al., 2007b) (Figure 2). It is unclear whether sleep problems 
in various chronic inflammatory conditions such as asthma (Janson et al., 1996), 
systemic lupus erythematosus (Gudbjörnsson and Hetta, 2001), rheumatoid 
arthritis (Bourguignon et al., 2003), and in IBD (Keefer et al., 2006;Ranjbaran 
et al., 2007a) are primarily the results of the disease-associated symptoms (pain, 
stress, depression), medical treatment (corticosteroid), or disease-related immune 
changes (Ranjbaran et al., 2007b).
A poor night’s sleep may exacerbate disease symptoms of chronic inflammatory 
conditions, such as IBD, and this effect is presumably intermediated by the 
changes that sleep deprivation causes on immune functioning (Ranjbaran et al., 
2007b). In adults with IBD, sleep quality is inversely correlated with IBD activity 
(Ranjbaran et al., 2007a). Before disease activation, IBD patients often experience 
a significant stress (Levenstein et al., 2000;Mawdsley and Rampton, 2006). Thus, 
it is hypothesised that sleep deprivation could serve as one form of physiological 
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stress that could cause disease flare-ups (Ranjbaran et al., 2007b;Tang et al., 2009) 
(Figure 2). This has been investigated in a study using animal models. In that study, 
sleep deprivation was unable to cause bowel inflammation per se but could, indeed, 
cause worsening in inflammation status in a previously inflamed bowel (Tang et 
al., 2009). Furthermore, sleep patterns have been noticed to relate with colonic 
movement patterns (Furukawa et al., 1994;Narducci et al., 1987;Roarty et al., 1998). 
During slow-wave sleep, the propagating activity of the colon is eliminated and the 
bowel rests. Arousals and awakenings cause immediate stimulation of the colon 
as the propagating activity of the colon increases. Thus, changes to sleep patterns 
due to activation of the immune system and frequent arousals during sleep may 
cause less slow-wave sleep, thus giving less time for the colon to recover. This may 
further increase IBD symptoms (Furukawa et al., 1994;Keefer et al., 2006;Narducci 
et al., 1987;Roarty et al., 1998).
A questionnaire-based study of adult patients with IBD (n=80) reports that 
sleep quality correlated with IBD disease severity (Ranjbaran et al., 2007a). In 
that study, 66% of IBD patients assessed their sleep as poor during disease flare-
ups, 49% believed that their inflammatory disease and GI symptoms could be 
affected by disturbed sleep, and 27% of the IBD patients thought that chronic sleep 
deprivation could cause disease flare-ups (Ranjbaran et al., 2007a). Such studies 
in paediatric IBD are so far lacking. In juvenile idiopathic arthritis (JIA), which is 
another paediatric chronic inflammatory condition, sleep has been shown to be 
more frequently disrupted and disturbed in those with active disease compared to 
healthy controls (Bloom et al., 2002;Passarelli et al., 2006). However, surprisingly 
the self-reported and PSG measured sleep quality was similar in the groups of active 
and inactive JIA (Ward et al., 2008). Here, studies concerning sleep in paediatric 
JIA patients are reviewed more closely as an example of paediatric inflammatory 
condition, since studies on sleep in paediatric IBD are so far lacking. 
4.2.1.1.	 Sleep	in	juvenile	idiopathic	arthritis	(JIA)
JIA is an autoimmune inflammatory disease among children. Similar to IBD, the 
disease course in JIA is unpredictable, with fluctuating periods of active and inactive 
phases. Children with JIA experience joint inflammation and swelling, morning 
stiffness and limited mobility, pain and tenderness, and they fatigue easily. In JIA, 
sleep quality and/or daytime tiredness have been explored in four studies (Bloom 
et al., 2002;Passarelli et al., 2006;Ward et al., 2008;Zamir et al., 1998). 
Zamir G et al (1998) was the first to assess sleep patterns in children with JIA 
(n=16; age 12 ± 4 years) in a study, which also included controls (n=9; age 11 ± 3 years) 
(Zamir et al., 1998). Subjects completed a questionnaire, which assessed subjective 
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perception about sleep hygiene and sleep quality, and also asked for personal details 
and disease history. Additionally, sleep was monitored by an objective method 
(PSG). The groups did not differ according to self-reported sleep quality but the 
patients reported more daytime tiredness (longer afternoon naps) than the controls. 
PSG revealed significant differences in objectively measured sleep in these two 
groups. Sleep in JIA patients was fragmented as they had 90% more arousals and 
awakenings than controls. Furthermore, the median length of uninterrupted deep 
sleep in stages 2 and 3 and rapid eye movement (REM) sleep was shorter, whilst 
state shifts from deep to lighter sleep stages were more frequent in patients with JIA 
than in controls. Group difference was non-significant for sleep latency, total sleep 
time, sleep efficiency, or time spent in any sleep stage (Zamir et al., 1998). Thus, the 
main findings here were that in JIA, children have increased daytime tiredness and 
their night’s sleep is more fragmented compared to controls (Zamir et al., 1998). 
Comparable child and parent questionnaires, the Sleep Self-Report (SSR) and 
the Children’s Sleep Habit Questionnaire (CSHQ), were used in a retrospective study 
of 25 children with active JIA to assess sleep and its relation to pain, dysfunction, 
and disease activity, and the results were compared to those of 45 healthy age and 
gender-matched subjects (Bloom et al., 2002). Parents of JIA patients reported 
significantly higher total scores on the CSHQ (p<0.001) and on the subscales 
assessing night-waking, parasomnias, sleep-related anxiety, sleep-disordered 
breathing, and morning waking/daytime tiredness than parents of healthy controls. 
The total CSHQ scores or CSHQ subscale scores did not correlate with any disease 
variables. However, the total SSR score correlated with the presence of pain but 
not with other arthritis-related variables. The authors did not provide any other 
data on SSR scores. A complete report on the total and subscale scores on SSR in 
patients compared to controls are lacking (Bloom et al., 2002).
Also, Passarelli CM et al. (2006) used subjective questionnaire-based methods 
and objective PSG to investigate sleep in 21 patients with active JIA and 20 healthy 
controls (Passarelli et al., 2006). This study reports that pain and daytime functional 
impairment of adolescents with active JIA (n=21) are related to sleep fragmentation 
(Passarelli et al., 2006). Patients had more frequent leg movements and arousals 
and higher alpha-activity in non-REM sleep in PSG recordings compared to controls. 
However, self-reported sleep complaints did not differ between the groups (Passarelli 
et al., 2006). In contrast to the earlier studies (Bloom et al., 2002;Zamir et al., 1998), 
this study failed to find significant group difference in daytime tiredness between 
JIA patients and controls (Passarelli et al., 2006).
Ward TM et al. (2008) compared objectively (PSG) and subjectively measured 
(self-reported questionnaires) sleep, JIA symptoms (pain, fatigue), and anxiety 
between children with active (n=35) and inactive JIA (n=35) (Ward et al., 2008). 
There was no difference in PSG sleep variables between these groups but patients 
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with active JIA reported more pain and fatigue (p<0.02 for both) compared to those 
with inactive JIA. Of the children with active JIA, 54% and with inactive JIA 28% 
reported trouble sleeping, and 41% and 22%, respectively, reported waking up at 
night. However, there was no group difference in how rested they felt themselves in 
the morning as only approximately 10% in both groups reported not feeling rested 
in the morning (Ward et al., 2008). 
4.2.2. impaired sLeep among those with somatic heaLth probLems
Stomach ache is a crucial symptom of active IBD. Pain in several forms (headache, 
abdominal pain, limb pain, back pain), have been reported to associate with sleep 
disturbances (Long et al., 2008;Roth-Isigkeit et al., 2005). Among school-aged 
patients with chronic pain frequency of parent-reported sleep troubles were above 
the clinical cut-off point in 53% of the cases (Long et al., 2008). Chronic pain 
associates with higher frequency of arousals at bedtime and lower sleep quality 
(Palermo et al., 2011). Irritating gastrointestinal (GI) symptoms can also disturb 
sleep (Lewin and Dahl, 1999). Children with IBS (in which symptoms are somewhat 
similar to IBD without GI inflammation) have been reported to have significantly 
more sleep disturbances, emotional problems and anxiety than healthy controls 
(Iovino et al., 2009). Furthermore, compared to healthy controls, children with 
functional abdominal pain report more symptoms of behavioural sleep disorders and 
increased nightmares and daytime tiredness (Huntley et al., 2007). Sleep of healthy 
adolescents (n=20) and those with chronic pain (n=20) was studied by self-reports 
and actigraphy (Palermo et al., 2007). In that study, adolescents with chronic pain 
demonstrated similar total sleep time than their healthy peers, but they reported 
significantly poorer sleep quality and increased insomnia. In actigraphy recordings, 
lower sleep efficiency and more arousals were present among those with chronic 
pain than in the control group. Pain, depressive symptoms, and worry at bedtime 
predicted subjectively reported impaired sleep quality (Palermo et al., 2007). In 
children with JIA, pain but no other JIA-related symptoms positively correlated 
with self-reports of sleep disturbances (Bloom et al., 2002). 
4.2.3. somatic symptoms in sLeep-troubLed individuaLs
Sleep-troubled individuals suffer from several somatic complaints and diseases 
more often than those whose sleep is not disturbed (Taylor et al., 2007). Long-
term sleep disturbances increased the risk of somatic health problems in a large 
study assessing health and function of adolescents (n=3134) suffering from chronic 
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insomnia (Roberts et al., 2008b). Sleep trouble associates with somatic symptoms 
like fatigue, less energy, symptoms of headache, stomach ache, backache, and 
worse perceived health (Gau, 2000;Liu et al., 2007;Tynjälä et al., 1993;Vignau et 
al., 1997). Somatic complaints and pain often coexist with sleep trouble (Lewin and 
Dahl, 1999;Stein et al., 2001). For example, in a large study of school-aged children 
(n=472), all five sleep factors (parasomnia, enuresis, tiredness, noisy sleep and 
insomnia) were significantly associated with emotional and behavioural problems 
but also with somatic complaints and attention problems according to parents’ 
reporting (CBCL) (Stein et al., 2001). In a Finnish study, significant correlations 
were found between sleep time measured by actigraph and teacher-reported somatic 
symptoms among healthy 7 to12-year-old children (n=49) (Aronen et al., 2000). 
Insufficient quantity and quality of sleep may lower the threshold for pain by 
causing psychosocial changes, which weaken coping skills necessary for effective 
pain management (Lewin and Dahl, 1999). 
4.2.4. concLusion
Association between disturbed sleep and somatic symptoms (e.g. in various 
inflammatory conditions) may be reciprocal. For example, pain may cause sleep 
disturbances, and disturbed sleep can either cause an increase in somatic symptoms 
through stress and changes in immune functions, or by lowering threshold for pain 
and thus resulting in more severe subjective experience of pain (Figure 3). 
figure 3. Association between sleep trouble, disease symptoms, and inflammation process.
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4.3. sLeep probLems and associating psychosociaL  
 symptoms in paediatric popuLation 
Adequate sleep in adolescence is important for healthy development and proper 
daytime functioning. Evidently, associations exist between disturbances in the 
quantity and quality of sleep and various psychosocial symptoms in children and 
adolescents from normal and clinical, mainly psychiatric, populations. So far, these 
associations have not been investigated in adolescents with paediatric IBD. 
In children and adolescents, poor quality and an inadequate amount of 
sleep have a negative impact on cognitive functioning and development, mood 
regulation, academic and social performance, behaviour, and overall quality of life 
(Dahl, 1996;Fallone et al., 2002;Lavigne et al., 1999;Owens et al., 2005;Sadeh et 
al., 2002;Smaldone et al., 2007). The association between subjective or parent-
reported sleep trouble and emotional problems (e.g. anxiety, depressive symptoms, 
and depression) is unarguable and seems to become stronger as children mature 
into adolescence and adulthood (Alfano et al., 2009;Gregory and O’Connor, 
2002;Johnson et al., 2000;Roberts et al., 2002). Half of the adolescents with 
lifetime diagnosis of insomnia report one or more comorbid psychiatric disorders 
(mood, anxiety, behavioural, and/or substance use disorders) (Johnson et al., 2000), 
and half of children with persistent sleep disturbances referred to a paediatric 
sleep medicine centre (n=46) had another psychiatric diagnosis (most commonly 
attention-deficit hyperactivity disorder (ADHD), anxiety, or mood disorder) 
(Ivanenko et al., 2004a). In depressed children and adolescents, sleep trouble 
associates with severe depression (Liu et al., 2007).
Sleep disturbances and insufficient sleep in healthy children are typically 
associated with behavioural problems such as irritability, decreased attention, 
distractibility, impulsivity, hyperactivity, excessive daytime tiredness, chronic 
fatigue, decrements in daytime alertness and performance, school absence and 
increased risk of injury (Aronen et al., 2000;Ferber, 1996;Owens et al., 2005). 
Objectively measured quantity of sleep (actigraphy) associates with behavioural 
problems at school in a non-clinical sample of school-aged children (Aronen et al., 
2000). Furthermore, primary sleep problems can even be misdiagnosed as ADHD 
in children (Dahl, 1996). Recently, insomnia was correlated with tobacco and alcohol 
use, perceived economic status and school performance in a non-clinical sample of 
Greek adolescent high-school students (n=2195) (Siomos et al., 2010).
Existing longitudinal studies reveal that sleep problems in adolescence predict 
emotional and behavioural problems (e.g. substance use disorder) in adulthood in 
population-based surveys (Fichter et al., 2009). On the other hand, those adults 
who have a history of poor sleep and insomnia are more likely to develop depression 
than those without such history (Breslau et al., 1996;Ford and Kamerow, 1989). 
41
Prospective studies on sleep difficulties among the general paediatric population 
suggest that sleep problems early in life predict development of depression and 
anxiety in later years (Gregory and O’Connor, 2002). Inadequate sleep in adolescents 
also predicted lower self-esteem in addition to emotional problems (Fredriksen et 
al., 2004) and, according to another study, somatic health problems, interpersonal 
problems, psychological problems and problems with daily activities (Roberts et al., 
2008b). Association between sleep trouble and emotional symptoms seems to be 
bidirectional (Dahl and Lewin, 2002). Depressive symptoms also seem to predict 
sleep disturbances (Patten et al., 2000). 
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aims of the study
The aim of this study was to determine the psychosocial burden experienced 
by Finnish adolescents with paediatric inflammatory bowel disease (IBD), and 
among them to evaluate the frequency of sleep problems and daytime tiredness in 
comparison with population-based matched controls. In this study, the information 
was gathered from both the parents and the adolescents, and, thus, the degree 
of parent-adolescent agreement regarding psychosocial symptoms and somatic 
complaints was also evaluated. 
The main objectives of this thesis were:
1) To evaluate parent and self-reported emotional and behavioural symptoms 
and competence in adolescents with IBD in relation to their population-based 
controls, and to evaluate these symptoms in the patient group according to 
disease symptom severity (Study I).
2) To investigate the degree of parent-adolescent agreement regarding emotional, 
behavioural, and somatic symptoms in adolescents with IBD (Study II).
3) To assess parent and self-reported sleep problems and daytime tiredness in 
adolescents with IBD in relation to their population-based controls, and in 
patients, to assess these problems according to the severity of IBD symptoms 
(Study III).
4) To evaluate how sleep trouble associates with psychosocial symptoms and 
somatic complaints among adolescents with IBD according to parent and self-
reports (Study IV). 
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study design, suBjects and methodology
1. study design
This study applies cross-sectional study design and includes adolescents with IBD 
and their population-based controls. All the studies of this thesis (I, II, III and 
IV) are based on the data, which was collected as a postal questionnaire-based 
survey in spring 2007. Reports were obtained from both parent and adolescent 
informants. Geographically this study covered the whole Finland (Figure 4). Three 
separate questionnaires were used to assess psychosocial symptoms and sleep 
in study subjects: CBCL to be completed by a parent, and YSR and SSR to be 
completed by an adolescent. Additionally, a background enquiry of the disease was 
sent to the adolescents with IBD. Both parental and adolescent questionnaires were 
posted to adolescent’s address. Parents and adolescents returned the completed 
questionnaires separately in envelopes provided. The cost of postage was prepaid. 
2. study suBjects
2.1. patients with ibd
Contact information of 300 patients aged 10 to 18, who were diagnosed during 1994-
2006 with paediatric IBD according to the files of the Social Insurance Institution, 
was accessed from the database of the Population Register Centre. Postal addresses 
were available for 287 such patients. The questionnaires were sent to these 287 
patients and their parents in spring 2007. One reminder was sent to 175 patients 
who had not replied within two months. Two patients with recent diagnosis (less 
than 1 year) were excluded. The final study group includes 160 patients (56%) and 
their parents. Parental CBCL questionnaires were mainly completed by mothers 
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(91%), fathers completed the remainder (9%). The mean age of the patients at 
onset of the disease was 10 years (SD= 3.3, range 1–15 years) (see patients’ disease 
characteristics in Table 4). Only the parent-adolescent dyads, who returned both 
the parental and self-reports, were included in the agreement analyses (n=156) 
(II). Study IV includes only the patients who answered in the YSR item assessing 
sleep trouble (n=157). 
table 4. Disease characteristics of the adolescents (n=160) in the patient group.
number of adolescents with 
diagnosis of iBd, uc, cd, and 
ic, and gender distribution 
duration of  
iBd in years
self-reported severity of  
iBd symptoms on a scale from 
1 (asymptomatic) to  
7 (extremely severe)
diagnosis n mean (SD) mean (SD)
IBD 160 5.2 (3.3) 2.3 (1.5)
UC 83 (52%)
- Boys 33 (40%)
5.1 (3.5) 2.1 (1.4)
CD 53 (33%)
- Boys 36 (68%)
5.4 (3.2) 2.5 (1.5)
IC 19 (12%)
- Boys 11 (58%)
4.7 (3.4) 2.7 (1.9)
Inflammatory bowel disease (IBD); ulcerative colitis (UC); Crohn’s disease (CD); intermediate 
colitis (IC) 
2.2. popuLation-based controLs
The postal address for three controls matched for age, gender, and place of residence 
per each adolescent with IBD were randomly selected from the database of the 
Population Register Centre (n=861) (Figure 4, Table 5). Controls are included in 
studies I and III.
Study questionnaires were sent to these 861 controls and their parents. One 
reminder was sent to the control adolescents and their parents if none of the three 
matched controls of a patient returned questionnaires. The final control group 
includes 236 (27%) adolescents and their parents. Biological mothers completed 
the vast majority (90%) of the CBCL questionnaires. 
As analysed by demographic and descriptive characteristics (age, gender, place 
of residence and socio-economic status) the groups of patients and controls did not 
differ significantly and represented the whole country well (Figure 4, Table 5). The 
non-respondents in the patient and control groups did not differ from respondents 
according to age, gender, or place of residence (SES data not available). 
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Socio-economic	status	(SES)
SES was based on parent and adolescent reports on the level of education of both 
parents’. The higher socio-economic class of the parents was considered as the 
socio-economic class of the family. SES was classified according to Helsinki City 
socio-economic statistics (Bruun, 1954;Järvenpää, 1964).  
table 5. Demographic data on patients (n=160) with inflammatory bowel disease and controls (n=236).
Patients controls
age Mean (SD) 15.4 (2.2) 15.2 (2.2)
gender
- Boys 85 (53%) 115 (49%)
social-economic status (ses)
- Class I 35 (22%) 72 (30%)
- Class II 66 (41%) 85 (36%)
- Class III 52 (33%) 70 (29%)
- Class IV 7 (4%) 11 (5%)
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figure 4 illustrates the reference hospitals for the adolescents with inflammatory bowel disease (n=160) 
and their population-based controls (n=236) (adapted from Väistö et al., 2010). 
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3. methodology
3.1. background data and disease severity
The participating patients received a background enquiry, in which they were asked 
to report the severity of IBD symptoms during the preceding week, age at onset of 
the disease, and the sub-diagnosis of the disease (UC, CD, IC to double-check that 
the responder had IBD). The severity of IBD symptoms was reported in a numerical 
visual analogy scale (VAS) shown visually as a line from 1 (asymptomatic) to 7 
(extremely severe). In studies I and III, IBD patients were divided into two groups 
according to the self-reported severity of IBD symptoms: patients with mild IBD 
symptoms (VAS scores 1-3; n=121) and patients with severe IBD symptoms (VAS 
scores 4-7; n=35). Comparable numerical VAS scoring from 1 to 7 has been used 
in earlier studies about quality of life in Finnish IBD patients (Pakarinen et al., 
2009;Turunen et al., 2009). 
3.2. Questionnaires assessing psychosociaL  
 symptoms and competence
3.2.1. chiLd behavior checkList (cbcL)
Parent-rated psychosocial symptoms and competence of the adolescents were 
assessed using the standardised CBCL questionnaire for which comprehensive 
reliability and validity evidence is available (Achenbach and Rescorla, 2001). The 
questionnaire is designated for parents of 6-18-years old children. The questionnaire 
was translated into Finnish by the Child Psychiatric Clinic of Helsinki University 
Hospital in 2002. The questionnaire consists of 113 problem items rated according 
to three response alternatives (0 = not true; 1 = somewhat or sometimes true; 2 = 
very true or often true). These problem items generate eight narrow-band syndrome 
scales of the CBCL, which in turn comprise broad-band scales of Emotional 
(Internalising) and Behavioural (Externalising) Symptoms. These two broad-band 
scales, together with narrow-band syndrome scales of Social Problems, Thought 
Problems, and Attention Problems comprise the Total Symptoms scale (Table 6). 
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The competence section of the CBCL includes seven items assessing adaptive 
behaviour and competence. These competence items inquire about specific activities 
and hobbies, amount of involvement in activities and relationships, and academic 
performance (Achenbach and Rescorla, 2001). The competence section includes 
three subscales called Activities, Social and School, which together comprise the 
scale of Total Competence (Table 6). 
Single problem items that are included in the narrow-band syndrome scale of 
Somatic Complaints (nightmares, dizziness, tiredness, aches, headaches, nausea, eye 
problems, skin problems, stomach aches, vomiting, and in the CBCL constipation) 
were utilised in studies I and IV.
3.2.2. youth seLf-report (ysr)
The adolescents completed the standardised YSR questionnaire, which evaluates self-
reported psychosocial symptoms and competence of 11 to 18-year-old children and 
adolescents (Achenbach and Rescorla, 2001). Items and scales in this questionnaire 
are similar and comparable to those in the CBCL (Table 6). However, there are a 
few exceptions: items about educational services and school grade repetition are 
not included in the YSR. Thus, School Competence is not scored for YSR but raw 
data for academic performance is included (Achenbach and Rescorla, 2001). To 
define somatic symptoms, there is a question about constipation in the CBCL but 
not in the YSR. Like CBCL, YSR is a reliable and valid questionnaire (Achenbach 
and Rescorla, 2001). Here, the Finnish translation of the questionnaire was applied. 
A few patients were Swedish-speaking, and thus received a Swedish version of the 
questionnaire.
3.2.3. cLinicaL and subcLinicaL cut-off points in the cbcL and ysr
The Achenbach system generates T-scores to all broad-band scales, narrow-
band syndrome scales, and competence scales. T-scores are reported to make the 
evaluation of clinical significance of psychiatric symptoms and competence easier 
and to enable comparison with other parallel studies (Achenbach and Rescorla, 
2001). Table 7 introduces the subclinical and clinical cut-off points for the different 
scales.
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table 7. Subclinical and clinical cut-off points for the Child Behavior Checklist (CBCL) and Youth Self-
Report (YSR) scale scores.
subclinical clinical
Ps
yc
ho
so
ci
al
 P
ro
bl
em
s
Broad-band scales of Total, Internalising, 
and Externalising Symptoms 60 ≤ T-score ≤ 63 T-score > 63
Narrow-band syndrome scales 65 ≤ T-score ≤ 70 T-score > 70
co
m
pe
te
nc
e Total Competence 37 ≤ T-score ≤ 40 T-score < 37
Subscales of Activities, Social Competence, 
and School 30 ≤ T-score ≤ 35 T-score < 30
3.3. Questionnaires assessing sLeep troubLe and  
 daytime tiredness
3.3.1. sLeep seLf-report (ssr)
Besides YSR, adolescents were asked to complete a structured SSR questionnaire 
for a more detailed report of their sleep habits (Owens et al., 2000). The SSR 
questionnaire is a standardised subjective retrospective measure of sleep habits 
for school-aged children (Owens et al., 2000), and it was translated into Finnish 
in 2004. The questionnaire is divided into two sections. The first section includes 
three background questions on sleeping (Who in your family sets the rules about 
when you go to bed? Do you think you have trouble sleeping? Do you like to go 
to sleep?). In the second section, single items are allocated to three subscales to 
describe Bedtime (12 items), Sleep Behaviour (seven items), and Daytime Tiredness 
(four items) (Table 8). Response options for these items are “Often” (5-7 times per 
week), “Sometimes” (2-4 times per week), and “Seldom or never” (0-1 time per 
week). Items are rated on a three-point scale, and for each subscale sum-scores 
are formulated. Six items are scored inversely due to inverse question design. The 
minimum and maximum sum-scores consequently are from 12 to 36 for Bedtime, 
from 7 to 21 for Sleep Behaviour, and from 4 to 12 for Daytime Tiredness. A higher 
score indicates more sleep problems. 
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In addition, we included two extra sleep-related questions for adolescents with 
IBD: “Do IBD symptoms affect the quality of your sleep?” and an open question: 
“If yes, how?” Adolescents were advised to answer these questions according to 
their sleep habits over the preceding six-month period.
Of the SSR, 86% in the patient group and 89% in the control group were 
completed by the adolescents themselves, the rest were completed with the help 
of another person. The proportion of self-completed SSR-questionnaires did not 
significantly differ between the groups of patients and controls (p=0.332).
In study IV, sleep quality scales of the SSR (Bedtime, Sleep Behaviour) were 
utilised to analyse correlations between sleep quality and psychosocial issues. 
table 8. Items included in the subscales of Bedtime, Sleep Behaviour, and Daytime Sleepiness in the 
questionnaire of Sleep Self-Report (SSR). 
sleep self-report (ssr)
Bedtime sleep Behaviour daytime sleepiness
-  Do you go to bed at the 
same time every night on 
school nights?
-  Do you fall asleep in the 
same bed every night?
-  Do you fall asleep alone?
-  Do you fall asleep in your 
parents’, brother’s or sister’s 
bed? 
-  Do you fall asleep in about 
20 minutes?
-  Do you fight with your 
parents about going to bed?
-  Is it hard for you to go to 
bed?
-  Are you ready for bed at 
your usual bedtime?
-  Do you have a special item 
(doll, blanket, etc.) that you 
take to bed?
-  Are you afraid of the dark? 
-  Are you afraid of sleeping 
alone?
-  Do you stay up late when 
your parents think you are 
asleep?
-  Do you think you sleep too 
little?
-  Do you think you sleep too 
much?
-  Do you wake up at night 
when your parents think you 
are asleep?
-  Do you have trouble falling 
back to sleep if you wake up 
during the night?
-  Do you have nightmares?
-  Does pain wake you up at 
night?
-  Do you sometimes go to 
someone’s bed during the 
night?
-  Do you have trouble waking 
up in the morning?
-  Do you feel sleepy during 
the day?
-  Do you take naps during the 
day?
-  Do you feel rested after a 
night’s sleep?
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3.3.2. sLeep items in the cbcL 
The five problem items dealing with sleep and tiredness in the CBCL questionnaire 
were utilised in the current study in order to measure parent-rated sleep and daytime 
tiredness in adolescent patients and controls (III) (Table 9).
3.3.3. sLeep items in the ysr
In addition to the SSR, five problem items dealing with sleep and tiredness in the 
YSR were used to measure adolescent self-rated sleep and tiredness in the study 
III (Table 9). For the fourth study (IV), the patient group was subdivided into 
the groups of sleep-troubled (20%, n=32) and non-sleep-troubled (80%, n=125) 
according to their own reports on the sleep trouble item of the YSR (“I have trouble 
sleeping”) in order to evaluate psychosocial and somatic symptoms that associate 
with sleeping difficulties. 
table 9. List of sleep-related items in the Child Behavior Checklist (CBCL), and comparable items in the 
Youth Self-Report (YSR).
cBcl ysr
-  Nightmares (Item 47)
-  Overtired without good reason (Item 54)
-  Sleeps less than most kids (Item 76)
-  Sleeps more than most kids during day and/
or night (Item 77)
-  Trouble sleeping (Item 100)
-  I have nightmares (Item 47)
-  I feel overtired without good reason (Item 
54)
-  I sleep less than most kids (Item 76)
-  I sleep more than most kids during day and/
or night (Item 77)
-  I have trouble sleeping (Item 100)
3.4. statisticaL anaLysis
Statistical analyses were performed using SPSS 15.0-17.0 software for Windows. 
CBCL and YSR items were scored using ADM (version 6.5) scoring software 
(Achenbach 1999-2006). 
Mean group differences for broad-band scale scores of the CBCL/YSR were 
statistically tested with t-test for independent samples. For narrow-band scale scores 
of the CBCL/YSR and sum-scores of the SSR subscales, mean group differences were 
tested with the non-parametric Mann-Whitney U-test. Cross-tabulation and non-
parametric Chi-Square tests were used to analyse and statistically test the parent and 
self-reported frequencies with which the IBD and control adolescents scored over 
the subclinical/clinical cut-off points on the broad-band and narrow-band scales 
of the CBCL/YSR. Additionally, the Linear-by-Linear test (a Chi-Square variation) 
was used for trend-analyses of single somatic and sleep-related items in the CBCL/
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YSR, and ANOVA-test for variance was used to analyse mean group differences for 
broad-band scales of CBCL/YSR scores among IBD adolescents with various types 
of IBD (UC, CD and IC) and for various locations of residence (Helsinki, Kuopio, 
Tampere, Turku and Oulu). For correlation analyses we used the two-tailed Pearson 
correlation. In agreement analyses, Cohen’s kappa (κ) served to measure agreement 
between parent and adolescent reports on dichotomised variables (e.g. broad-band 
and narrow-band T-scores of CBCL/YSR in the normal range versus those in the 
subclinical/clinical range). Kappa-values were categorised as poor (≤ 0.20), low 
(0.20 – 0.40), moderate (0.40 – 0.60), and nearly perfect (> 0.80) (Landis and 
Koch, 1977). Statistical significance was set at p ≤ 0.05.
3.5. ethics
The Ethics Committee for Gynaecology and Obstetrics, Paediatrics and Psychiatry 
of the Hospital District of Helsinki and Uusimaa approved the study protocol. 
Answering the questionnaires was optional and did not have any influence on 
clinical examinations and treatment of the patients.
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results
1. Psychosocial symPtoms and comPetence  
 among adolescents with iBd (i)
1.1. compared to popuLation-based controLs
Parents in the patient group reported in their children significantly higher mean 
T-scores in the CBCL scales of Total Symptoms, Emotional Symptoms, Social 
Problems, Thought Problems, and nearly significantly higher mean T-scores for 
Attention Problems (p=0.059) than the parents of population-based controls (Table 
10). Furthermore, adolescents with IBD scored significantly higher mean T-scores 
for all narrow-band syndrome scales included in the broad-band scale of Emotional 
Symptoms than the controls according to the parents (Table 10). Group difference 
in the scale of Behavioural Symptoms was non-significant. Total Competence was 
significantly lower among the adolescents with IBD than the controls. However, the 
group differences in the subscales of Activities, Social, and School Competence were 
non-significant according to parent-reports (Table 10). The number of adolescents 
scoring over the clinical cut-off point for Emotional Symptoms was significantly 
higher in the group of patients (n=35, 22%) than controls (n=16, 7%; p<0.001) 
according to the parents’ reports.
There was no significant group difference in the YSR scales indicating self-
reported psychosocial symptoms and competence between adolescents with IBD 
and their population-based controls. In both groups, all mean T-scores were below 
the subclinical cut-off points. Adolescents with IBD also reported a similar amount 
of single somatic symptoms than the controls.
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table 10. Mean T-scores for the Child Behavior Checklist scales as reported by the parents in the patient 
and control groups (adapted from Väistö et al., 2010). 
iBd Patients controls
mean t-score (sd) mean t-score (sd) p
total symptoms 50 (15) 46 (12) <0.001
emotional symptoms 56 (6.4) 49 (4.9) <0.001
- Anxious/Depressed 53 (2.6) 52 (2.1) <0.001
- Withdrawn/Depressed 57 (2.8) 54 (2.1) <0.01
- Somatic Complaints 63 (3.2) 57 (1.9) <0.001
Behavioural symptoms 48 (5.1) 47 (4.4) ns
- Rule-breaking behaviour 53 (2.1) 53 (2.3) ns
- Aggressive behaviour 53 (3.7) 52 (3.0) ns
other syndrome scales
- Social Problems 52 (1.6) 52 (1.4) <0.05
- Thought Problems 54 (1.5) 53 (1.6) <0.001
- Attention Problems 53 (2.8) 53 (2.5) ns
total competence 46 (4.6) 48 (4.0) <0.05
- Activities 45 (2.6) 47 (2.5) ns
- Social 47 (2.4) 49 (2.2) ns
- School 49 (0.9) 50 (0.8) ns
ns= non-significant; IBD= Inflammatory Bowel Disease
1.2. according to severity of ibd symptoms
The patients were divided into two subgroups according to the self-reported severity 
of IBD symptoms (see the background enquiry). Most of the patients (n=121) 
reported having mild IBD symptoms (IBD symptom severity ranging from 1 to 3). 
Thirty-five patients suffered from severe IBD symptoms (IBD symptom severity 
ranging from 4 to 7). Table 11 illustrates in bold those CBCL and YSR broad-band 
and narrow-band scales for which the parents and the adolescents themselves 
reported significantly higher (p<0.05) mean T-scores among those with severe 
IBD symptoms compared to those with mild IBD symptoms.
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table 11. The patients with severe IBD symptoms scored significantly (p<0.05) higher mean T-scores 
compared to those with mild IBD symptoms in those scales which are illustrated in bold here according 
to the parents (CBCL, Child Behavior Checklist) and the adolescents themselves (YSR, Youth Self-Report). 
cBcl ysr
total symptoms total symptoms
emotional symptoms emotional symptoms
- anxious/depressed mood - Anxious/Depressed mood
- withdrawn/depressed mood - withdrawn/depressed mood
- somatic complaints - somatic complaints
Behavioural symptoms Behavioural Symptoms
- Rule-breaking behaviour - Rule-breaking behaviour
- aggressive behaviour - Aggressive behaviour
According to self-reports, gender associated significantly with emotional 
symptoms so that girls reported more emotional symptoms (p<0.05), anxious/
depression (p<0.01), and somatic complaints (p<0.01) than boys. Boys in turn 
reported lower total competence compared to girls (p<0.05). Furthermore, academic 
performance was significantly better in girls than in boys (p=0.001). Gender 
difference in total symptoms and behavioural symptoms was non-significant. 
Subtypes of IBD (UC, CD, and IC), duration of the disease, SES, or place of 
residence did not significantly associate with the psychosocial symptoms reported 
by either parents or adolescents themselves. 
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2. Parent-adolescent agreement on  
 Psychosocial symPtoms and somatic  
 comPlaints in Paediatric iBd (ii) 
4.1. degree of agreement
In paediatric IBD, agreement on psychosocial symptoms between parents and 
adolescents was altogether poor to low (κ-values ranged from 0.00 to 0.38), and 
it was closer regarding emotional (κ = 0.34) than behavioural symptoms (κ = 0.15). 
The agreement rate was very poor on the syndrome scales of Anxious/Depressed 
mood (κ = 0.02) and Aggressive Behaviour (κ = 0.12); whilst it was poorest in the 
syndrome scale of Thought Problems (κ = 0.00). On the syndrome scales of Somatic 
Complaints and Attention Problems the degree of agreement was low (κ = 0.22, κ 
= 0.28, respectively) and on Social Problems it was close to moderate (κ = 0.38).
4.2. freQuency with which the patients scored in the 
subcLinicaL/cLinicaL range according to parent and 
seLf-reports
Parent and adolescent-reported frequencies with which adolescents scored over the 
subclinical limit were mostly similar in all CBCL/YSR broad-band and syndrome 
scales. Only in the scale of Somatic Complaints, the parents reported significantly 
higher frequency with which the adolescents scored over the subclinical cut-off 
point than the adolescents themselves did (CBCL 44%, n = 68; YSR 14%, n = 21; p 
< 0.001). In the broad-band scale of Behavioural Symptoms (p = 0.069) and in the 
syndrome scale of Social Problems (p = 0.064) the difference was nearly significant. 
In both of these scales, adolescents reported scores over the subclinical limit more 
often than their parents did. 
Figure 5 illustrates the frequencies with which patients scored over the subclinical 
cut-off point (T-score ≥ 60) in the broad-band scales of the CBCL and YSR 
questionnaires according to parental and adolescent reports (“Both”), parental or 
adolescent reports (“Parent alone”; “Adolescent alone”), and neither parental nor 
adolescent reports (“Neither) (Figure 5). In 5% of the cases, parents and adolescents 
agreed that the adolescent had significant psychosocial problems and in 74% of the 
cases they agreed that the problems were lacking. Disagreement existed in 21% of 
the cases (Figure 5a).
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figure 5. Frequency with which the adolescent patients with inflammatory bowel disease score over the 
subclinical limit (T-score ≥ 60) in the Emotional, Behavioural, and Total Symptom scales of the Child Behavior 
Checklist and Youth Self-Report according to parent and/or adolescent reports (“Both”, “Parent only”, 
“adolescent only”) and neither parent nor adolescent reports (“Neither”) (adapted from Pirinen et al., 2012).
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3. sleeP ProBlems and daytime tiredness  
 among adolescents with iBd (iii)
3.1. compared to popuLation-based controLs
According to the CBCL items, significantly more adolescents with IBD (25%, 
n=40) than controls (13%, n=29, p<0.01) had trouble sleeping sometimes or often. 
Furthermore, parents of IBD patients reported overtiredness (p<0.001), nightmares 
(p<0.01), and more sleeping during the day and/or night (p<0.001) in their child 
significantly more often than the parents of controls did. 
According to the sleep-related items in the YSR, no significant difference was 
evident in frequency of trouble sleeping or overtiredness between adolescents with 
IBD and controls. In the patient group, 32 (20%) reported having trouble sleeping 
sometimes or often and respective figures for controls were 54 (23%, p=0.366).
In the SSR questionnaire item “Do you think you have trouble sleeping?” 11% of 
patients (n=16) and 13% of controls (n=31) reported having sleep trouble (p=0.429). 
No difference emerged between the patients and controls in the SSR subscale scores 
(Bedtime, Sleep Behaviour, Daytime Sleepiness) or the total sum-scale scores of 
the SSR (all p’s>0.27). 
3.2. according to severity of ibd symptoms
Parents reported that significantly more patients with severe IBD symptoms 
(41%, n=14) had trouble sleeping sometimes or often than patients with mild 
IBD symptoms (22%, n=25; p<0.01). In addition, significantly more adolescents 
with severe IBD symptoms (80%, n=28) were sometimes or often overtired than 
their counterparts with mild IBD symptoms (44%, n=53; p<0.001). No significant 
differences were present in CBCL scores regarding the diagnosis (CU, CD, and IC).
According to the sleep-related items in the YSR, 39% (n=13) of adolescents with 
severe IBD symptoms and 16% (n=19) of adolescents with mild IBD symptoms 
reported trouble sleeping sometimes or often. The group difference was significant 
(p=0.003). Of the adolescents suffering from severe IBD symptoms, 73% (n=24) 
described being overtired sometimes or often. The number was also high among 
adolescents with mild IBD symptoms since every second one of them (52%, n=62) 
reported overtiredness. The group difference was, however, significant (p=0.001).
On the total sum-scale of SSR, patients with severe IBD symptoms had higher 
mean scores than patients with mild IBD symptoms (p=0.032), indicating that 
the former had altogether more sleep problems. On the Sleep Behaviour subscale, 
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patients with severe IBD symptoms reported more sleep problems than patients with 
mild IBD symptoms, and the group difference approached significance (p=0.064). 
On the Sleep Behaviour subscale, adolescents with severe symptoms reported more 
problems than adolescents with mild symptoms on the items “Do you wake up at 
night when your parents think you are asleep?” (p=0.010) and “Does pain wake 
you up at night?” (p=0.003).
Patients with severe symptoms reported significantly more daytime sleepiness 
than patients with mild symptoms (Daytime Sleepiness subscale of the SSR, 
p=0.034). A significant difference was evident between patient groups on Daytime 
Sleepiness subscale items “Do you take naps during the day?” and “Do you feel 
rested after a night’s sleep?”, where adolescents with severe IBD symptoms reported 
significantly higher mean scores than adolescents with mild IBD symptoms 
(p=0.043 and p=0.001, respectively). The group difference in the SSR subscale of 
Bedtime was non-significant.
In the entire patient group, 17% (n=27) reported that IBD symptoms affect the 
quality of their sleep. Significantly more adolescents with severe IBD symptoms 
(n=15; 43%) reported that disease symptoms affect the quality of their sleep than 
adolescents with mild IBD symptoms (n=12; 10%; p<0.001)). No significant 
differences were present in the YSR or SSR regarding the diagnosis (CU, CD, and IC).
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4. Psychosocial symPtoms and somatic  
 comPlaints that associate with sleePing  
 difficulties in adolescents with iBd (iv) 
4.1. reLation between sLeep troubLe and  
 psychosociaL symptoms
According to the parental reports, sleep-troubled adolescents scored significantly 
higher mean T-scores for total problems (p=0.008), anxiety/depression (p=0.023), 
somatic complaints (p<0.001), and aggressive behaviour (p=0.006) than adolescents 
not reporting sleep trouble. In the CBCL scale of Attention Problems, the group 
difference was non-significant. 
The adolescent patients reported similar associations between sleep trouble and 
psychosocial symptoms than their parents did. In self-reports, sleep-troubled patients 
scored significantly higher mean T-scores for total problems (p=0.001), anxiety/
depression (p=0.002), somatic complaints (p<0.001), and aggressive behaviour 
(p=0.002) than adolescents with no sleep trouble. Additionally, adolescents with 
self-reported sleep trouble reported higher mean T-score for attention problems 
than adolescents without sleep trouble, although the difference was only close-to-
significant (p=0.083).
4.2. correLation between sLeep QuaLity and  
 psychosociaL symptoms 
The SSR scales indicating sleep quality (Bedtime, Sleep Behaviour) correlated 
significantly (all p’s <0.05) with the CBCL and YSR broad-band scales of Emotional 
and Behavioural symptoms and narrow-band syndrome scale of Attention Problems.
4.3. reLationship between sLeep troubLe and singLe  
 somatic symptoms
Of the single somatic symptoms, sleep trouble associated significantly with various 
aches and nausea in adolescents with IBD according to both parental and self-
reports (Table 12).
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table 12. Single Somatic Symptoms among Sleep-Troubled and Non-Sleep-Troubled Adolescents with 
Inflammatory Bowel Disease (Scale 0= Does not Apply, 1= Applies Somewhat, 2= Applies Well or Often) 
as reported by the Parents (Child Behavior Checklist, CBCL) and adolescents (Youth Self-Report, YSR). 
do you think you have trouble sleeping?
YES
n (%)
NO
n (%)
cBcl 0 1 2 0 1 2 p
Nightmares 14 (44) 16 (50) 2 (6) 91 (74) 32 (26) 0 (0) <0.001
Dizzy 21 (66) 11 (34) 0 (0) 108 (87) 15 (12) 1 (1) 0.009
Tired 9 (28) 17 (53) 6 (19) 65 (53) 53 (43) 5 (4) 0.001
Aches 9 (28) 21 (66) 2 (6) 75 (61) 42 (34) 6 (5) 0.004
Headaches 13 (41) 16 (50) 3 (9) 69 (56) 48 (39) 6 (5) 0.097
Nausea 18 (56) 11(34) 3 (9) 97 (79) 22 (18) 4 (3) 0.009
Eye problems 30 (94) 1 (3) 1 (3) 106 (88) 12 (10) 2 (2) 0.607
Skin problems 15 (47) 11 (34) 6 (19) 71 (57) 41 (34) 11 (9) 0.129
Stomach aches 5 (16) 16 (50) 11 (34) 48 (38) 63 (51) 13 (11) <0.001
Vomiting 25 (78) 6 (19) 1 (3) 112 (90) 10 (8) 2 (2) 0.084
Constipation 25 (78) 6 (19) 1 (3) 108 (88) 15 (12) 0 (0) 0.085
ysr
Nightmares 12 (38) 18 (56) 2 (6) 76 (61) 48 (39) 1 (1) 0.007
Dizzy 21 (66) 11 (34) 0 (0) 98 (78) 25 (20) 2 (2) 0.226
Tired 5 (16) 22 (69) 5 (16) 64 (51) 56 (46) 4 (3) <0.001
Aches 17 (53) 13 (41) 2 (6) 94 (76) 25 (20) 5 (4) 0.025
Headaches 11 (34) 19 (59) 2 (6) 75 (61) 43 (35) 5 (4) 0.013
Nausea 19 (59) 12 (38) 1 (3) 104 (84) 18 (15) 1 (1) 0.002
Eye problems 26 (81) 5 (16) 1 (3) 109 (89) 10 (8) 3 (3) 0.299
Skin problems 14 (44) 12 (38) 6 (19) 72 (59) 42 (33) 10 (8) 0.062
Stomach aches 11 (34) 16 (50) 5 (16) 82 (67) 38 (30) 4 (3) <0.001
Vomiting 27 (84) 5 (16) 0 (0) 118 (95) 5 (4) 1 (1) 0.083
Linear-by-Linear test (a Chi-Square variation) for statistical significance. Statistically significant differences 
are indicated in bold.
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1. Psychosocial symPtoms in adolescents  
 with iBd (i)
This study supports the preliminary findings, which report that adolescents with 
IBD are at higher risk for parent-rated emotional and social dysfunction, and lower 
competence compared to healthy controls (Engström and Lindquist, 1991;Mackner 
and Crandall, 2006). Moreover, in line with earlier studies (Mackner and Crandall, 
2005), the current study reports that adolescents with IBD and the control 
adolescents suffer from similar frequencies of self-rated psychosocial symptoms, 
referring either to patients’ positive adaptation to the disease or alternatively to the 
denial of psychosocial symptoms and the disease’s negative impact on everyday life.
Here, as reported by the parents, 22% of the patients suffered from a clinical 
amount of emotional symptoms, which was significantly more than in the control 
group (7%). Even higher rates of psychopathology in paediatric IBD patients, mainly 
diagnoses of depression and anxiety, have been reported earlier in interview-based 
studies (60-73%) (Engström, 1992;Szajnberg et al., 1993) and similar rates in a 
questionnaire-based study (25%) (Szigethy et al., 2004). 
Parental opinion of the child’s mental well-being is of great importance as it 
complements self-reports and offers another point of view to the child’s psychosocial 
problems. However, parental concerns related to the child’s illness (Akobeng et al., 
1999a) may cause the parental reports to be overestimating. Parents of chronically 
ill children may also observe their children more sensitively than parents of healthy 
children, which may partly contribute to the differences found in the parent-reported 
frequencies of psychosocial symptoms between adolescents with IBD and their 
controls.
Interestingly, in the current study the adolescents with IBD reported similar 
frequencies of psychosocial and somatic symptoms on themselves to the controls. 
This result is in line with another previous report using the same YSR questionnaire 
(Mackner and Crandall, 2005). Lack of group difference in the self-reported 
frequency of psychosocial symptoms may either indicate denial and underestimation 
of psychosocial problems or, on average, good psychosocial well-being among these 
patients. As a coping strategy, chronically ill adolescents may take an indifferent 
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attitude towards their symptoms (Akobeng et al., 1999b). Previously, a tendency to 
deny symptoms have been characterised in the paediatric IBD population in two 
interview-based studies (Engström, 1992;Szajnberg et al., 1993). Engström I (1999) 
describes that the interviews were challenging to carry out because children and 
adolescents with IBD were reluctant to discuss, used short one-word sentences to 
reply and gave concrete, emotionally thin answers (Engström, 1999). Furthermore, 
healthy children seem to have tendency to report more psychopathology in 
themselves than their parents do (Sweeting and West, 1998;Weissman et al., 1987) 
and the situation may be opposite in children which chronic somatic condition. These 
factors may partly explain the lack of group difference between the self-reports of 
patients and controls in the current study. Self-administered questionnaires may 
not be efficient enough to assess mental and social well-being of the adolescents 
with IBD and, thus, complementary measurements should be applied.
Due to cross-sectional study design, conclusions of causal connections between 
the onset of IBD and impaired psychological functioning, as reported by the parents, 
are impossible. Earlier studies indicate that depressive symptoms and disorders 
develop after IBD diagnosis; on the other hand, anxiety may precede the diagnosis 
in these patients (Burke et al., 1994b). Most existing studies in this field used earlier 
psychopathology in patients as exclusion criteria.
This study reports that self-rated IBD symptom severity and psychosocial 
dysfunction are positively associated in paediatric IBD patients in Finland, as 
reported by the parents and the patients themselves. However, it is impossible to 
tell whether worsening of IBD symptoms caused impaired psychosocial functioning 
or whether psychiatric factors influenced on the worsening of IBD symptoms. In 
the light of the literature, both causal ways are possible (see the chapter entitled 
Relationship between psychological factors and disease severity). In previous 
studies, disease severity has been noted to be one of the major predictor of fatigue 
and depression in adolescents with IBD (Szigethy et al., 2004). Depression may 
also predispose these adolescents to disease flare-ups. Several studies suggest 
that psychological stress may worsen the symptoms of IBD (Bernstein et al., 
2006;Maunder, 2005;Mawdsley and Rampton, 2005). Contrary to our results, 
Mackner LM (2005) found no association between YSR emotional symptoms and 
disease factors, which may be explained by the different evaluation of the severity 
of IBD symptoms (subjective symptoms, physical examination, and laboratory 
tests) (Mackner and Crandall, 2005); in the current study the evaluation of disease 
symptom severity was based solely on subjective report. The results here do not 
permit the drawing of any conclusions about the possible psychosocial etiology 
of IBD.
Treatment of paediatric IBD aims to decrease the number of relapses of 
the disease and lengthen remission. Additionally, improving quality of life and 
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psychosocial functioning of these children/adolescents are also important goals. 
Evaluation of the psychosocial symptoms should be included in all clinical visits. 
Especially those adolescents who report severe IBD symptoms may suffer from 
significant psychological stress and impairment, and they should be evaluated for 
emotional and social problems more carefully and proper support and treatment 
should be offered. Few studies exist on how to help IBD adolescents who suffer from 
depressive and anxiety symptoms and restricted social functioning. IBD adults with 
psychosocial stress benefited from IBD-focused psychological counselling, which 
improved psychological well-being and lessened IBD-related somatic symptoms and 
disease severity (Wahed et al., 2010). A review article suggests that antidepressants 
(paroxetine, bupropion, and phenelzine) are effective for treating both psychological 
and somatic symptoms in adults with IBD (Mikocka-Walus et al., 2006). Subjective 
need for psychological interventions have been documented to be more frequent in 
adult patients with IBD than those with rheumatoid arthritis, as 31% in the former 
and 13% in the latter group expressed a need for this kind of therapy (Miehsler 
et al., 2008). In IBD, the need for psychological support given by the physician 
was associated with worries and concerns related to the disease, and the need for 
psychotherapy associated with worries and concerns about IBD, anxiety, impaired 
social functioning, and short disease duration (Miehsler et al., 2008). In paediatric 
IBD, cognitive-behavioural therapy has been proven to be effective in emotional 
symptoms (Keller et al., 2004;Szigethy et al., 2007;Szigethy et al., 2009). Mood 
improvement was independent from the improvements in the IBD symptomatology 
(Szigethy et al., 2009). Organising peer support could be one way of improving 
psychosocial well-being in paediatric patients with IBD. For instance, attending 
IBD summer camp has been noted to improve these patients’ (n=61, age range 9-16 
years) HRQoL and social functioning, to increase their understanding of the disease, 
and to lower distress related to the treatment interventions (Shepanski et al., 2005).
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2. Parent-adolescent agreement on  
 Psychosocial symPtoms and somatic  
 comPlaints (ii) 
Objective evaluation of psychosocial problems and mental well-being of an individual 
paediatric patient is challenging during short clinical visits. Using different sources 
of information often complement the whole picture of patient’s psychosocial 
symptomatology. Thus, the evaluation is often based on clinical interviews with 
the patient and/or the parent or on questionnaires completed by either or both 
respondents. In addition, reports from teachers or other adults who know the patient 
well can be utilised in the evaluation process. Agreement analyses aim to clarify 
how similarly the different respondents evaluate various symptoms on an individual 
patient. The current study investigated the degree of parent-adolescent agreement 
on psychosocial and somatic symptoms in paediatric IBD using standardised CBCL/
YSR questionnaires. This issue is of great importance in order to make individually-
designed treatment plans for paediatric patients with IBD.
The degree of parent-adolescent agreement was here altogether poor to low on the 
presence of psychosocial and somatic problems in the adolescents with IBD. Among 
them, 10% of significant psychosocial symptoms would have remained unrecognised 
if only the adolescents or the parents were asked. Earlier, similarly low agreement 
rates have been reported among paediatric psychiatric and normal populations 
(Achenbach et al., 1987;Ferdinand et al., 2006;Kolko and Kazdin, 1993;Rothen et 
al., 2009;Salbach-Andrae et al., 2009a;Sourander et al., 1999). Comparable studies 
that investigate agreement on psychosocial and somatic symptoms between parents 
and adolescents among somatically ill paediatric patients are few. In asthma, a 
low agreement rate was reported on the presence of anxiety and depression (κ = 
0.18) (Rockhill et al., 2007). Similarly, an interview-based study revealed poor to 
low degree of parent-adolescent agreement (κ = 0.08-0.29) among chronically ill 
children (cancer, cystic fibrosis, IBD, and insulin-dependent diabetes) (Canning, 
1994). 
The current study reports higher agreement rate between adolescents with IBD 
and their parents regarding Emotional (κ = 0.34) than Behavioural Symptoms 
(κ = 0.15) which is opposite to earlier studies carried out among both in the 
community and clinical populations (Kolko and Kazdin, 1993;Salbach-Andrae et 
al., 2009a;Salbach-Andrae et al., 2009b;Yeh and Weisz, 2001). In the CBCL/YSR 
questionnaires, the broad-band scale of Emotional Symptoms includes the scale of 
Somatic Complaints, where the κ-value was highest of the three syndrome scales 
67
included in the Emotional Problems, and may thus partly explain this result. Mutual 
conversation on somatic symptoms between parents and adolescents is presumably 
easier than on symptoms related to mental well-being, depression and anxiety. 
Notably, agreement in the syndrome scale of Anxious/Depression was extremely 
poor (κ=0.02), and thus a conclusion that in IBD parents and adolescents agree 
more on emotional than behavioural problems is problematic. 
On average in the whole patient group, parents and adolescents reported similar 
frequencies with which the patients scored over the subclinical limit on most of the 
broad-band and syndrome scales. This is in line with an earlier study which assessed 
psychiatric disorders in children with chronic conditions, including some children 
with IBD (n = 11). In that study, parents and children in the IBD group reported 
similar frequencies of emotional (18%) and behavioural (9%) disorders in these 
patients, whereas in other chronic illness groups, parents reported more frequent 
psychiatric disorders in their children than the children themselves did (Canning, 
1994). In the current study, parents reported significantly more often symptoms in 
the subclinical/clinical range in the scale of Somatic Complaints than the adolescents 
themselves did, which may reflect parental stress and concerns about the child’s 
disease. The adolescents, in turn, scored themselves more often in the subclinical/
clinical range on the scales of Behavioural Symptoms and Social Problems than 
their parents did, possibly indicating that the parents of adolescents with IBD may 
be unknowing of the behavioural and social concerns that their children have. Even 
if frequencies of patients scoring in the subclinical/clinical range in the CBCL/
YSR scales were mostly similar, the parents and adolescents seemed to disagree 
on who the individual patients are that suffer from psychosocial symptoms on the 
subclinical-clinical range. 
Even though utilising different sources of information can complement the whole 
picture of a patient’s psychosocial well-being, inconsistent reports may be problematic 
in the clinician’s point of view. In clinical settings, knowing the factors that may 
contribute to the parent-adolescent agreement regarding adolescent’s emotional and 
behavioural issues would help clinicians to interpret gained information correctly. 
These possible factors include e.g. a child’s age and gender (Berg-Nielsen et al., 
2003;Verhulst and van der Ende, 1992) and parental psychosocial well-being or lack 
of it (Martin et al., 2004). Furthermore, parental psychosocial symptomatology has 
been shown to contribute to parental evaluation of the child (Treutler and Epkins, 
2003). Here, parental psychosocial problems and problems in the families stayed 
undefined and unanalysed, and in the analyses the effect of age and gender of the 
patient on the degree of agreement remained undetermined. Furthermore, the 
agreement rate between mother and adolescent and father and adolescent, which 
has been earlier documented to vary (Seiffge-Krenke and Kollmar, 1998;Vassi et 
al., 2008), was not studied separately in the current study.
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3. sleeP trouBle and its relation to  
 Psychosocial and somatic symPtoms in  
 adolescents with iBd (iii, iv) 
So far, only one earlier study handling sleeping problems in paediatric IBD patients 
published as an abstract exists (Nachmias et al., 2006). The current study assessed 
the frequency of parent and self-reported sleep problems and daytime tiredness 
among adolescents with IBD by five sleep-related items in the CBCL and YSR 
questionnaires and by the standardised Sleep Self-Report (SSR). Importantly, 
parental reports complement self-reports here and offer another point of view on 
sleeping difficulties among young patients with IBD. However, a lack of objective 
measurements of sleep such as polysomnography (PSG) or actigraphy can be 
considered a weakness of the current study. On the other hand, subjective self-
reports of sleep have proven to correlate with objective measures of sleep difficulties 
in paediatric populations (Gaina et al., 2004;Iwasaki et al., 2010).
3.1. prevaLence of sLeep troubLe and daytime  
 tiredness in adoLescents with ibd compared to  
 heaLthy controLs
Comparable to the findings in the study assessing psychosocial symptoms in 
adolescents with IBD (I), no significant group difference emerged in the frequency 
of self-reported sleep problems, sleep quality, and daytime tiredness (YSR, SSR) 
between adolescents with IBD and their population-based controls. These results 
are inconsistent to what has earlier been reported in adult IBD patients (Keefer 
et al., 2006;Zimmerman, 2003) or in JIA patients (Bloom et al., 2002;Zamir et 
al., 1998). Subjective sleep quality reported on the Pittsburgh Sleep Quality Index 
(PSQI) was poorer among adult patients with inactive IBD compared to their healthy 
controls (Keefer et al., 2006). However, no group differences emerged according to 
daytime dysfunction between these two groups (Keefer et al., 2006). Furthermore, 
JIA patients reported themselves suffering from daytime tiredness significantly 
more often than their healthy controls (Bloom et al., 2002;Zamir et al., 1998). In 
one study JIA patients, however, reported a similar frequency of sleeping problems 
than the controls (Passarelli et al., 2006).
Although no significant group difference emerged here in self-reports between 
patients and controls, parents in the patient group did report significantly more 
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sleep problems and daytime tiredness (CBCL) in their children than the parents of 
controls. Similarly in JIA, parents have reported more sleep-related problems and 
daytime tiredness in their children with JIA than the parents of healthy controls 
(Bloom et al., 2002). 
In the current study, about 20% of the adolescents in both groups reported 
suffering from sleeping problems sometimes or often (YSR), which is in line with 
previous epidemiological studies concerning prevalence of sleep problems in the 
child and adolescent population (Holmberg and Hellberg, 2008;Owens et al., 
2000;Paavonen et al., 2000). However, this frequency is lower compared to the 
previous report of sleep problems among adolescents with IBD (54%) (Nachmias 
et al., 2006). Interestingly, in the current study, parents of the controls reported 
much lower prevalence of sleep problems in their children (13%) compared to the 
self-reports (23%), while the parents in the patient group recognised sleep problems 
in their children at a similar rate (25%) as what is earlier shown to be the prevalence 
of such problems in children/adolescents. This may suggest that in control group 
the parents are unaware of their child’s sleeping difficulties. 
Approximately 10-30% of adolescents are reported to suffer from excessive 
daytime tiredness according to parent and adolescent reports (Holmberg and 
Hellberg, 2008;Owens et al., 2000). However, in the current study the frequency 
of self-reported daytime tiredness seemed to be much higher in both patient and 
control groups, as 57% of the patients and 56% of the controls reported suffering 
from overtiredness sometimes or often. The inconsistency between the results of 
these studies may be explained by methodological differences. Owens et al (2000) 
used teacher’s reports to rate frequency of daytime sleepiness among school-aged 
children (Teacher’s Daytime Sleepiness Questionnaire) (Owens et al., 2000) but here 
the frequency was self-rated. Of adult patients with inactive IBD, 79% needed to take 
naps during the day, referring to decreased daytime energy and increased daytime 
tiredness among them (vs. 50% of the controls) (Ranjbaran et al., 2007a). In this 
study, parents in the patients group reported comparable frequency of overtiredness 
in their children than the patients (52%) but the parents of controls reported much 
lower frequency (31%) compared to their children. 
3.2. freQuency of sLeep probLems and daytime  
 tiredness according to ibd symptom severity
In the patient group, both respondents reported significantly more sleep problems 
and overtiredness (CBCL, YSR) in those with severe IBD symptoms compared 
to those with mild IBD symptoms. This was also evident in the SSR subscale of 
Daytime Sleepiness, where those with severe symptoms scored significantly higher 
70
Discussion
than those with mild IBD symptoms. Here, nearly half (43%) of the patients with 
severe IBD symptoms report that the disease and its symptoms affect the quality 
of their sleep. Similarly, 43% of adult IBD patients have earlier reported that GI 
symptoms have an impact on their sleep (Keefer et al., 2006), and in another 
study 66% of adult IBD patients thought their sleep was poor in active states of the 
disease (Ranjbaran et al., 2007a). Comparable to the psychosocial symptoms (I), 
frequencies of sleep problems or daytime tiredness did not differ between patients 
with different subtypes of the disease (UC, CD, IC).
Patients with severe IBD symptoms seem to suffer from more frequent sleep 
interruptions than those with mild IBD symptoms, and one reason for frequently 
interrupted sleep may be the several somatic symptoms of the disease (SSR item 
“Does pain wake you up at night?” and the extra question “Do IBD symptoms 
affect the quality of your sleep?” in study III). Frequent sleep interruptions have 
been mentioned earlier by adult IBD patients (Ranjbaran et al., 2007a), and they 
have been objectively documented in paediatric patients with JIA (Passarelli et 
al., 2006;Zamir et al., 1998). Furthermore, chronic pain has been objectively 
documented to associate with frequent arousals during sleep (Palermo et al., 
2007;Palermo et al., 2011). Frequent sleep interruptions may explain the daytime 
tiredness, which was noticed here to be more common in young IBD patients with 
a severe disease course than those with mild IBD symptoms (III). Another possible 
explanatory factor here would be anaemia due to rectal bleeding or malnutrition 
(iron deficiency, B12 –vitamin deficiency) (Mamula et al., 2003).
In study IV, somatic symptoms (reported in CBCL and YSR questionnaires), 
especially various aches, associated with sleep trouble among the whole patient 
group. Those who have severe IBD symptoms presumably have more sleep-
disturbing aches and, thus, the group difference between those with severe vs. mild 
IBD symptoms was significant in the SSR item “Does pain wake you up at night?” 
Also, emotional symptoms which were found to be more common in adolescents 
with severe IBD symptoms than those with mild IBD symptoms (I) may affect 
their night’s sleep, causing sleep disturbances (Johnson et al., 2000;Patten et al., 
2000). In earlier studies, adult patients with IBD have listed reasons for their sleep 
interruptions: abdominal pain, need to use bathroom, breathing difficulty, snoring, 
feeling too cold or too hot, and nightmares (Ranjbaran et al., 2007a). In this study, 
nightmares were equally common in those with mild and severe IBD symptoms. 
Significantly more patients with severe IBD symptoms took naps during the day 
compared to those with mild IBD symptoms. Daytime tiredness negatively affects 
social life, free time activity and performance in school (Fallone et al., 2002;Vignatelli 
et al., 2004). Thus, in clinical work sleep problems and daytime tiredness should be 
assessed carefully, especially in those with severe IBD symptoms, and interventions 
to improve sleep quality among them should be applied. The current study was 
71
unable to classify and diagnose the prevailing sleep disorder (Ivanenko and Gururaj, 
2009) more specifically. That issue in patients with paediatric IBD should be 
assessed in future studies.
3.3. psychosociaL symptoms that associate with  
 sLeep troubLe in adoLescents with ibd
Adolescents and their parents reported very similar associations between sleep 
trouble and psychosocial symptoms on the young IBD patients. The similarity of 
the reports increases the reliability of these findings. According to both respondents, 
sleep trouble associated significantly with anxiety/depressed mood, aggressive 
behaviour, and somatic complaints (especially various aches). Sleep-troubled 
patients also scored more frequently above the subclinical limit on the YSR 
scale of Anxiety/Depressed mood than their counterparts without sleep trouble, 
indicating a significant number of emotional problems among the sleep-troubled 
individuals in this population. Earlier community-based studies have revealed 
comparable associations between sleep trouble and emotional symptoms (Alfano 
et al., 2009;Roberts et al., 2002). Also in young patients with JIA, a significant 
relationship between sleep trouble and anxiety has been documented (Ward et 
al., 2008).
In normative populations, significant associations have been revealed between 
sleep problems (e.g. objectively measured sleep amount and quality of sleep), and 
attention problems and working memory (Aronen et al., 2000;Dahl, 1996;Steenari 
et al., 2003;Stein et al., 2001). In line with this, parent and self-reported attention 
problems correlated significantly with SSR-measured sleep quality (SSR subscales 
on Bedtime and Sleep Behaviour). However, these associations were not evident 
when the single YSR sleep problem item was utilised to classify patients into those 
with sleep trouble and those without. This difference might be caused because of a 
more profound assessment of sleep in the SSR.
Sleeping problems associate with various behavioural problems in children 
and adolescents (Aronen et al., 2000;Ferber, 1996;Owens et al., 2005), including 
problems with aggression and emotional control (Aronen et al., 2000;Dahl, 
1996;Lavigne et al., 1999;Stein et al., 2001). Similarly, in this study, sleep-troubled 
patients had more parent and self-reported behavioural problems and problems 
with aggression. Sleeping difficulties are known to impact negatively on social 
performance and academic competence (Dahl, 1996;Smaldone et al., 2007). The 
associations of these aspects of behaviour were not included in the current study 
but they might be an interesting topic for future analyses.
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3.4. singLe somatic symptoms that associate with  
 sLeep troubLe in adoLescents with ibd
As mentioned earlier, sleep trouble associated significantly with mean T-scores on 
the CBCL/YSR scales of Somatic Complaints. In addition, the frequency of patients 
scoring over the subclinical limit on the scale of Somatic Complaints was significantly 
higher among sleep-troubled than non-sleep troubled adolescents with IBD 
according to both respondents. Therefore, in this study, single somatic symptoms 
included in the scale of Somatic Complaints were analysed more closely between 
these two groups. Results revealed that among young IBD patients, sleep trouble 
associated mainly with various parent and self-reported aches, which is in line with 
what is earlier documented concerning the associations between aches/pain and 
sleep (Lewin and Dahl, 1999;Palermo et al., 2007;Palermo et al., 2011;Stein et al., 
2001). Pain and sleep are interrelated: pain has a negative impact on the initiation 
and maintenance of sleep (Lewin and Dahl, 1999). Insufficient sleep, in turn, has 
been shown to increase the perception of pain (Moldofsky and Scarisbrick, 1976) and 
to impair coping skills necessary for effective pain management (Lewin and Dahl, 
1999). Children with somatic complaints tend to report more sleep problems than 
those without these complaints (Bruusgaard et al., 2000). Furthermore, sleeping 
difficulties may cause reporting more comorbid somatic complaints (e.g. chronic 
pain and gastrointestinal problems) (Taylor et al., 2007). 
According to the current cross-sectional study it is impossible to tell whether 
somatic symptoms, including abdominal pain, which is one of the leading somatic 
symptoms in IBD, led to trouble sleeping or whether deficient sleep induced 
more aches in adolescents with IBD. In the future, longitudinal studies should be 
administered to clarify causal connections between sleeping problems and IBD-
related somatic complaints.
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4. methodological considerations
The methodological strengths of the current study are: the use of standardised and 
validated questionnaires to measure psychosocial symptoms and sleep, gathering 
the information from both parent and adolescent respondents, large sample size and 
sample distribution across Finland of the patient group, and inclusion of population-
based controls matched for age, gender, and place of residence.
4.1. Questionnaires 
The Child Behavior Checklist (CBCL) and Youth Self-Report (YSR) are popular 
screening instruments used to identify children and adolescents with impaired 
psychosocial functioning for further evaluation and intervention. They are used 
both in clinical and research settings. CBCL/YSR questionnaires are not diagnostic. 
However, many studies have reported moderate to high levels of associations 
between CBCL/YSR scores and diagnoses derived from structural psychiatric 
interviews (Ferdinand, 2008;Hofstra et al., 2001;Krol et al., 2006;Petty et al., 
2008;van Lang et al., 2007). The questionnaires have been used in studies including 
various paediatric populations, as well as paediatric IBD patients (Brown et al., 
1991;Brown et al., 1992;Canning et al., 1992;Daltroy et al., 1992;Wood et al., 1987). 
Use of the CBCL/YSR with children and adolescents with chronic somatic illnesses 
has been criticised because the narrow-band syndrome scale of Somatic Complaints 
is included into the broad-band scale of Emotional Symptoms, which may potentially 
cause overestimation of emotional symptoms and elevation in the total symptom 
scores (Perrin et al., 1991). However, it is also argued that in physically ill adolescents, 
it is nevertheless essential to include somatic items in the assessment of emotional 
symptoms, because exclusion would cause failure to find the individuals suffering 
from marked depressive symptoms (Szigethy et al., 2009). Comprehensive reliability 
and validity checks are available for the CBCL/YSR questionnaires internationally 
(Achenbach and Rescorla, 2001). The Finnish translations, however, have not yet 
been systematically validated in the Finnish population. One possible response bias 
concerning the posted questionnaires is that the parent and adolescent respondents 
have discussed the questionnaires at home.
Assessment of sleep difficulties was based on validated and standardised Sleep 
Self-Report (SSR) (III, IV). SSR measures self-rated sleep problems in three 
subscales: Bedtime, Sleep Behaviour, and Daytime Sleepiness. Comparable parent-
assessment of sleep (Children’s Sleep Habits Questionnaire, CSHQ) was not included 
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in this study. However, the five sleep items in the CBCL were utilised to obtain 
parental perception of their child’s sleep and daytime tiredness. 
In study IV, only one YSR item was used to divide the patient group into sleep-
troubled and non-sleep-troubled in order to assess somatic and psychosocial 
symptoms in these two subgroups. The item is not standardised and refers only to 
self-perceived trouble sleeping. However, sleep trouble showed similar associations 
to psychosocial symptoms here to earlier studies, where sleep trouble has been 
objectively rated (Aronen et al., 2000;Ward et al., 2008). Additionally, in this study 
the adolescents and their parents reported similar associations between sleep trouble 
and psychosocial symptoms, which adds to the reliability of the gained results (IV). 
Furthermore, it can be argued that sleep trouble is mainly a subjective symptom 
and should therefore be subjectively rated. Earlier, similar method to determine 
sleep trouble has been used in a study which assessed the relationship between 
sleep trouble and anxiety/depression in children aged 6-11 years using CBCL and 
the Teacher Report Form (TRF) (Johnson et al., 2000). In that study, a child’s 
trouble sleeping was rated by the parent in the CBCL in a comparable manner as we 
did here (Johnson et al., 2000). In adolescents with chronic pain, subjectively, but 
not objectively, rated poor sleep quality has associated significantly with depressive 
symptoms and worry at bedtime (Palermo et al., 2007). The single question “Do you 
have trouble sleeping?” is applicable in clinical visits, and as the results here imply, 
those adolescents with IBD who admit to suffering from trouble sleeping should be 
further evaluated for psychosocial symptoms. However, in the future an objective 
measure of sleep disturbance (actigraphy/PSG) might be used when measuring 
connections between sleep trouble, and psychosocial and somatic symptoms in 
adolescents with IBD. 
4.2. participants
Although the response rate was only moderate, as only 56% of the patients replied, 
the number of patients included (n=160) was fairly high. The response rate was 
comparable to other Finnish questionnaire-based studies (Haapamäki et al., 2010). 
In earlier respective studies assessing psychosocial symptoms in paediatric IBD, 
the number of patients has been smaller, comprising less than 50 on average. 
Additionally, the patient group represented the whole Finland well. Here the item 
response rate was high, parents and adolescents answered at a parallel rate, and 
the questionnaires were properly completed. About the non-respondents can only 
be stated that they did not differ from respondents according to age, sex and place 
of residence, but the SES and severity of their disease are unknown. It might be 
either that their somatic and psychic health was so good that they did not consider 
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it necessary to answer or either their condition was so bad that they did not have 
the strength to make the effort to answer this questionnaire. As in earlier studies, 
there was no difference in reported psychosocial functioning between adolescents 
with UC or CD (Engström, 1992;Gold et al., 2000), and therefore they were analysed 
here as one IBD group. In addition, in agreement analysis the IBD group was 
analysed as one, although at least one earlier study suggests that there is a better 
parent-adolescent agreement rate in UC than in CD and that patients with CD 
report psychosocial symptoms at a higher rate compared to their parents (Wood 
et al., 1987). Study subjects were mostly white Scandinavians with homogeneous 
ethnic composition. Thus, results may not be generalised worldwide.
The postal addresses of the patients, who were entitled to reimbursement for IBD-
related medical costs according to Social Insurance Institution, were traced from the 
database of the Population Register Centre. The background inquiry asked about 
specific IBD diagnosis (CD, UC, IC) for double-checking that these patients really 
had IBD. The controls might have had some chronic somatic condition but these 
cases were not excluded. Possible confounding factors, e.g. family history of sleep 
disturbances or psychosocial issues, parental mental health, current stressors at the 
time of the study, family functioning in patients and controls were not evaluated. 
This would have been interesting, since family factors are known to associate with 
the frequency of behavioural problems in Finnish adolescents (Hurtig et al., 2005). 
The same applies to study IV, where it would have been interesting to see whether 
there were differences between groups of sleep-troubled and not-sleep troubled 
adolescents, according to other factors that might have explained the prevalence 
of psychosocial symptoms. It is known that family factors e.g. communication in 
the family (Burke et al., 1990;Tojek et al., 2002;Wood et al., 1989) and parental 
mental health (Burke et al., 1994b) influence on the psychosocial functions of young 
people with IBD, and these factors were not asked in the questionnaires. Moreover, 
another possible influencing factor – medication of the patients – was not included 
in the current study. For example, corticosteroids have a negative impact on sleep 
(Mrakotsky et al., 2005). Importantly, medication should be included in future 
studies on this field.
4.3. measuring the severity of ibd
Self-perceived disease severity has earlier been reported to correlate with objectively 
measured inflammatory status in IBD (Wood et al., 1987). Earlier studies on the 
relationship between severity of IBD and psychosocial symptoms have revealed 
inconsistent results (Table 2). In the current study the association was clear, but it 
may be biased by the method used to rate the disease severity. Depressed children 
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and adolescents may consider the disease symptoms more severe than their non-
depressed counterparts, even if their objectively-rated disease severity is similar. 
Subjectively-rated IBD symptom severity has been reported to correlate with affective 
symptoms better than objectively-rated IBD symptom severity (Ondersma et al., 
1997). After all, this study allows for the important conclusion that those children 
and adolescents who subjectively consider  that they are suffering from severe IBD 
symptoms should be further evaluated for psychosocial (I) and sleep problems (III) 
in order to find those cases that need and would benefit from treatment, including 
psychological counselling.
In the current study, disease severity was self-rated on a scale from 1 (asymptomatic) 
to 7 (extremely severe). The method used to determine IBD symptom severity 
has varied between earlier studies assessing psychosocial symptoms in patients 
with paediatric IBD, which impairs comparison between the achieved results. 
Earlier studies in this field have applied both objective evaluations of the disease 
severity (laboratory values, physician examination) and patient-reported disease 
symptoms (e.g. pain, number of stools, blood in stools) (Burke et al., 1989;Burke 
et al., 1990;Burke et al., 1994b;Wood et al., 1987). However, many of them have 
not included any kind of assessment of severity of the disease (Table 2). Because 
good validated non-invasive methods to rate IBD symptom severity exist (e.g. the 
Paediatric Ulcerative Colitis Activity Index, PUCAI (Turner et al., 2007;Turner et 
al., 2009); and the Paediatric Crohn Disease Activity Index, PCDAI (Leach et al., 
2010)) it is recommended to apply those instruments in future studies in order to 
make the comparison between results about the association of the severity of IBD 
and psychosocial symptoms easier. For example, PUCAI scores are formulated by 
patient-reported symptoms, which include abdominal pain, rectal bleeding, stool 
consistency, number of stools per 24 hour period, nocturnal stools that cause 
awakening, and patients’ activity levels (Turner et al., 2007). The PUCAI score is 
normally rated by a physician but could also reliably be rated by patients themselves 
(Lee et al., 2011). Thus, it could be used in future questionnaire-based studies, as well. 
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concluding remarks and future ProsPects
This study is the first one concerning psychosocial symptoms and sleep in paediatric 
IBD patients performed in Finland. It included more patient subjects than any 
earlier comparable study in this field. Additionally, a population-based control 
group matched for age, gender and place of residence was included. Furthermore, 
the data was collected from both the parents and the adolescents with widely used 
standardised measures. 
The main results of the present study suggest that in Finland, adolescents 
with IBD more often have emotional (depression, anxiety) and social problems, 
their sleep quality is more frequently impaired, and they are less competent than 
their healthy peers in the community. Emotional problems and sleep problems 
are present, especially if the adolescent rates his/her IBD symptoms as severe. 
Moreover, psychosocial symptoms, especially anxiety and depression, aggressive 
behaviour and difficulties related to attention, are likely to be present among 
patients who experience sleep disturbances in addition to those who report severe 
IBD symptoms. Surprisingly, the self-reported psychosocial symptoms including 
emotional, behavioural, and somatic symptoms, and sleep problems in the patient 
group did not differ from those in the control group. 
In the future, studies concerning psychosocial problems in adolescents with IBD 
should develop new ways to ask the adolescents about their symptoms, as it seems 
that it is difficult for them to report on their symptoms using questionnaires (Väistö 
et al., 2010) or in clinical interviews (Engström, 1992;Szajnberg et al., 1993). It 
may be necessary to create a trusting relationship with the adolescents before they 
can reveal more of their symptoms. Parents should be used as another source of 
information. It may also be possible to gain valuable information on psychosocial 
well-being of the patients from the teachers. Objective evaluation of the disease 
symptom severity, such as clinical examination and laboratory tests, should be 
included in future studies, in addition to a subjective one in order to draw conclusions 
about the relationships between inflammation processes and psychosocial problems 
among this paediatric population. Furthermore, it is recommended to collect data 
on medication used to control the inflammation and disease symptoms in study 
subjects, as they have earlier been reported to influence psychosocial symptoms 
and sleep parameters. To get a deeper understanding of the sleep quality in this 
population and in order to be able to specify the type of prevailing sleep disorder, 
objective evaluation of sleep (actigraphy/PSG) is recommended. Furthermore, 
objectively measured inflammation status and objective sleep recordings would 
clarify the causal relations between disease severity and inflammation, and sleeping 
difficulties. 
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conclusions 
The main results and conclusions can be summarised as follows:
(I) According to the parents but not the adolescents themselves, adolescents with 
IBD have more depressive symptoms and somatic complaints, impaired social 
functioning, and lower total competence than their peers in the community. 
Positive association emerged between self-perceived severity of IBD symptoms 
and parent and self-reported psychosocial symptoms. Other methods besides 
questionnaires should be applied when assessing the psychosocial well-being 
of IBD adolescents, as the questionnaires alone might be insufficient.
(II) Parent-adolescents agreement rate was poor to low in patients. Significant 
psychosocial and somatic symptoms would remain unnoticed if only the parent 
or the adolescent, instead of both, were asked. On average, parents report 
three times more serious somatic symptoms than the adolescents themselves, 
which possibly reflects parental stress as a result of the disease. They also 
may be unaware of behavioural and social concerns of their children, as the 
patients reported more serious behavioural and social problems themselves 
than the parents did. 
(III) Patients with severe IBD symptoms have trouble sleeping and overtiredness 
more often than patients with mild IBD symptoms or controls, according 
to both the adolescents and their parents. In adolescents with severe IBD 
symptoms, evaluation of sleep is important when estimating the disease 
burden. Further studies are needed to clarify the association between 
inflammation status and sleep quality in paediatric IBD. 
(IV) Parents and adolescents reported similar associations between sleep trouble 
and psychosocial symptoms in paediatric IBD. Trouble sleeping associated 
with anxious/depressed mood, aggressive behaviour, and somatic complaints 
including various aches. Furthermore, self-perceived poor sleep quality 
correlated significantly with parent and self-reported attention problems. 
Evaluations of sleep problems in clinical visits and interventions to improve 
sleep quality are important in this population. 
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